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General. All reactions were carried out under Ar. The solvents used were purified by 
distillation over the drying agents indicated and were transferred under Ar: THF, Et2O (Mg-
anthracene), CH2Cl2 (P4O10), MeCN, Et3N, pyridine, DMF (CaH2), MeOH (Mg), hexane, 
toluene (Na/K). Flash chromatography: Merck silica gel 60 (230-400 mesh). NMR: Spectra 
were recorded on a DPX 300, AV 400 or DMX 600 spectrometer (Bruker) in the solvents 
indicated; chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. 
IR: Nicolet FT-7199 spectrometer, wavenumbers in cm−1. MS (EI): Finnigan MAT 8200 (70 
eV), HRMS: Finnigan MAT 95, Bruker APEX III FT-ICR-MS (7 T magnet). Melting points: 
Büchi melting point apparatus (uncorrected). Elemental analyses: H. Kolbe, Mülheim/Ruhr. 
All commercially available compounds (Lancaster, Fluka, Aldrich) were used as received 
unless stated otherwise. 
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Ketoester 4. n-BuLi (1.6 M in hexane, 89 mL, 142.4 mmol) is slowly added to a solution of 
diisopropylamine (20 mL, 142.7 mmol) in THF (200 mL) at 0 °C. After stirring at 0 °C for 30 
min, the resulting LDA solution is cooled to –78 °C before tert-butyl acetate (19.5 mL, 144 
mmol) is added dropwise, and stirring is continued at that temperature for 60 min. A solution 
of lactone 3 (13.7 g, 57 mmol) in THF (10 mL) is then slowly added over 15 min at –40 °C, 
the reaction mixture is allowed to stir for another 2 h at that temperature before the cooling 
bath is removed and the reaction is quenched with sat. aq. NH4Cl and EtOAc. The organic 
layer is successively washed with aq. HCl (0.1 M) and sat. aq. NaHCO3, is dried over 
MgSO4, the solvent is evaporated and the crude product is purified by flash chromatography 
to give ketoester 4 as a colorless syrup which contains some double addition product (15.6 g, 
product ratio ≈ 5:1 (HPLC), corresponds to 61% of pure 4). This product was used in the next 
step without further purification. Characteristic data of compound 4: 1H NMR (300 MHz, 
CDCl3): δ 3.56 (2H, t), 3.26 (2H, s), 2.45 (2H, t), 1.50 (2H, m), 1.46 (9H, s), 1.20-1.30 (22H, 
bm). 13C NMR (75 MHz, CDCl3): δ 203.5, 166.5, 81.8, 63.0, 50.6, 42.9, 32.7, 29.6-29.4, 
28.3, 28.0, 27.9.  
Compound (R)-5. To a solution of [RuCl2(COD)]n (56 mg, 0.20 mmol) and (R)-BINAP (144 
mg, 0.23 mmol) in toluene (12 mL) is added Et3N (0.4 mL, 0.29 mmol) and the resulting 
mixture is stirred for 4 h at 140 °C. The solvent is removed and the residue is dissolved in 
THF (30 mL). This catalyst solution is added to a solution of ketoester 4 (crude product as 
described above, 4.41 g) in MeOH (100 mL) and the resulting mixture is stirred in an 
autoclave under H2 (15 atm) for 15 h at 70 °C. After the autoclave has been vented, the 
solvent is evaporated and the residue is purified by flash chromatography (hexane/ethyl 
acetate, 8:1) to give the desired diol (R)-5 (3.1 g, 88%) which exhibits the following analytical 
and spectroscopic data: [ ]D20α = −11.0 (c = 2.00, CDCl3). 1H NMR (400 MHz, CDCl3): δ 3.95 
(1H, m), 3.63 (2H, t), 2.47 (1H, dd, J = 5.4, 10 Hz), 2.31 (1H, dd, J = 6.6, 10.0 Hz), 1.56 (4H, 
m), 1.46 (9H, s), 1.20-1.40 (22H, m). 13C NMR (100 MHz, CDCl3): δ 172.6, 81.2, 68.2, 63.1, 
42.4, 36.5, 32.8, 29.7-29.4, 28.2, 25.8, 24.5. IR: 3398, 2924, 2852, 713, 1368, 1154, 1055 
cm−1. MS (ESI): m/z 381 ([M+Na]+). Anal. calcd. for C21H42O4: C 70.35, H 11.81, found C 
70.39, H 11.89. 
Compound 6. tert-Butyldiphenylchlorosilane (2.37 g, 8.6 mmol) and imidazole (0.67 g, 9.8 
mmol) are added to a solution of the diol 5 (3.10 g, 8.6 mmol) in DMF (80 mL). After stirring 
for 4 h at ambient temperature, the solution is concentrated to ca. the half of its volume. 
CH2Cl2 and water are then added, the organic layer is successively washed with aq. HCl (0.1 
M at 0 °C) and sat. aq. NaHCO3 before it is dried over MgSO4. The solvent is evaporated and 
the residue is purified by flash chromatography (hexane/ethyl acetate, 20:1) to give product 
(R)-6 as a colorless syrup (4.2 g, 81%). The enantiomeric excess (ee = 98%) is determined by 
HPLC by comparison with the racemate (98%, 250 mm Chiralcel OD-H, ∅ 4.6 mm, n-
heptane:2-propanol = 99:1, 0.5 mL/min, 298 K, 2.3 Mpa, UV, 220 nm). [ ]D20α = −6.9 (c = 
1.00, CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.65-7.68 (4H, m), 7.5-7.3 (6H, m), 3.95 (1H, 
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m), 3.66 (2H, t), 2.33 (1H, dd, J = 3.3, 10.0 Hz), 2.31 (1H, dd, J = 8.9, 10.0 Hz), 1.56 (4H, 
m), 1.44 (9H, s), 1.20-1.40 (22H, m), 1.04 (9H, s). 13C NMR (100 MHz, CD2Cl2): δ 172.8, 
136.3, 134.6, 129.8, 127.9, 81.2, 68.5, 64.4, 42.8, 37.0, 33.0, 30.0, 28.2, 27.5, 26.1, 25.7, 19.7. 
IR: 3440, 3071, 2929, 2855, 1708, 1589, 1428, 1368, 1153, 1112, 702 cm-1. MS (ESI): m/z 
619 ([M+Na]+). Anal. calcd. for C37H58O4Si: C 74.70, H 9.83, found C 74.58, H 10.01. 
Compound 8. Laevoglucosane 7 (16.60 g, 102 mmol) is slowly added to a suspension of 
NaH (11.29 g, 470 mmol) in DMF (300 mL) at 0 °C and the resulting mixture is stirred for 1 
h at ambient temperature until the evolution of gas has ceased. BnBr (75 mL, 631 mmol) is 
then slowly introduced over a period of ca. 1 h and stirring is continued until TLC shows 
complete conversion. The reaction is quenched by careful addition of MeOH (100 mL). Most 
of the DMF is removed under reduced pressure, EtOAc (300 mL) and water (100 mL) are 
added, the aqueous layer is extracted with EtOAc, the combined organic layers are washed 
with sat. aq. NaHCO3 and brine, dried over MgSO4, evaporated, and the residue is purified by 
flash chromatography (hexane/ethyl acetate, 10:1 → 4:1) to yield compound 8 (34.0 g, 77%). 
The analytical and spectroscopic data of the product thus obtained are in full agreement with 
those reported in the literature.1 [ ]D20α = −31.4 (c = 2, CHCl3). 
Compound 9. NaOAc (5.6 g, 68.3 mmol) is added to a solution of 1,6-anhydro-2,3,4-tri-O-
benzyl-β-D-glucopyranoside 8 (28.0 g, 65.6 mmol) in Ac2O (150 mL) and the resulting 
mixture is warmed to 36 °C. H2SO4 conc. (3 mL) is then added, the mixture is stirred for 5 
min before water (1 L) is introduced, and stirring is continued for 2 h. For work-up, the 
mixture is extracted with EtOAc, the combined organic layers are washed with sat. aq. 
NaHCO3 before being dried over MgSO4. Evaporation of the solvent gives compound 9 as a 
yellow oil (mixture of anomers, 33.4 g, 95%) which is used without further purification in the 
next step. The 1H and 13C NMR data are consistent with those previously reported.1 
Compound 10. A solution of 1,6-di-O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranoside 9 (18.00 
g, 33.7 mmol) and H2NNH2.AcOH (3.65 g, 39.5 mmol) in DMF (200 mL) is stirred at 
ambient temperature until TLC analysis shows complete conversion (~5 h). EtOAc and brine 
are added, the aqueous layer is extracted with EtOAc and the combined organic layers are 
successively washed with sat. aq. NaHCO3 and brine. Drying over MgSO4 and evaporation of 
the solvent gives a viscous oil which is purified by flash chromatography (hexane/ethyl 
acetate, 5:2) to yield compound 10 as a colorless oil (13.5 g, 81%). Its 1H and 13C NMR data 
are consistent with those previously reported in the literature.2 
Trichloroacetimidate 11. To a solution of 6-O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranose 10 
(13.5 g, 27.4 mmol) in trichloroacetonitrile (12 mL) and CH2Cl2 (140 mL) is added NaH (140 
mg, 0.2 eq.). Additional 275 mg of NaH (0.4 eq.) are added after 1 h. After 2 h reaction time, 
                                                 
1
 Bourke, D. G.; Collins, D. J.; Hibberd, A. I; McLeod, M. D. Aust. J. Chem. 1996, 49, 425-434. 
2
 Hoch, M.; Heinz, E.; Schmidt, R. R. Carbohydr. Res. 1989, 191, 21-28. 
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the mixture is filtered through Celite, the solvents are evaporated, and the residue is purified 
by flash chromatography (hexane/ethyl acetate, 4:1) to give compound 11 as a pale yellow oil 
(13.0 g, 74%). Its 1H and 13C NMR data are consistent with those previously reported in the 
literature.2 
Compound 12. A mixture of 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl 
trichloroacetimidate (11) (172 mg, 0.27 mmol), alcohol 6 (120 mg, 0.20 mmol), and 
molecular sieves 4Å in CH2Cl2 (3 mL) is stirred for 30 min at ambient temperature. The 
solution is then cooled to −78 °C prior to the addition of BF3.Et2O (3.5 µL) and stirring is 
continued at −40 °C for 2 h. The cooling bath is removed and the mixture is stirred for 30 min 
before it is filtered through a pad of Celite. The filtrate is diluted with CH2Cl2 and washed 
with sat. aq. NaHCO3, the organic layer is dried over MgSO4 and evaporated, and the crude 
product is purified by flash chromatography (hexane/ethyl acetate, 10:1) to give product 12 
(141 mg, 62%) as a colorless syrup. Moreover, 30 mg of alcohol 6 can be recovered. Data of 
glycoside 12: [ ]D20α = +8.1 (c = 2.25, CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.73-7.68 (4H, 
m), 7.50-7.20 (21H, m), 4.94 (2H, t, J = 11.0 Hz), 4.84 (1H, d, J = 10.9 Hz), 4.79 (1H, d, J = 
11.0 Hz), 4.72 (1H, d, J = 11.1 Hz), 4.56 (1H, d, J = 10.9 Hz), 4.51 (1H, d, J = 7.8 Hz), 4.30 
(1H, dd, J = 14.0, 1.7 Hz), 4.22 (1H, dd, J = 14.0, 4.4 Hz), 4.06 (1H, m), 3.68 (2H, t, J = 6.5 
Hz), 3.65 (1H, t, J = 9.0 Hz), 3.55-3.45 (2H, m), 3.37 (1H, dd, = J 7.8, 9.1 Hz), 2.70 (1H, dd, 
J = 5.5, 15.0 Hz), 2.40 (1H, dd, J = 7.7, 15.0 Hz), 2.04 (3H, s), 1.58 (4H, m), 1.43 (9H, s), 
1.40-1.20 (22H), 1.04 (9H, s). 13C NMR (100 MHz, CD2Cl2): δ 170.6, 170.5, 138.9, 138.8, 
138.3, 135.6, 134.4, 129.6-127.6, 103.1, 84.9, 82.3, 80.2, 77.8, 77.3, 75.6, 74.9, 74.7, 72.9, 
64.2, 63.2, 42.2, 34.5, 32.7, 29.9-29.5, 27.9, 26.8, 25.9, 25.5, 20.7, 19.2. IR: 3068, 2928, 
2855, 1743, 1730, 1604, 1497, 1454, 1154, 1110, 1093, 1073, 739, 701 cm-1. MS (ESI) m/z 
1093 ([M+Na]+). Anal. calcd. for C66H90O10Si: C 73.98, H 8.47, found C 74.06, H 8.41. 
Hydroxy Acid 13. A solution of glycoside 12 (875 mg, 8.2 mmol) and F3CCOOH (1.5 mL) 
in CH2Cl2 (10 mL) is stirred for 1 h at 0 °C and then at ambient temperature for another 2 h. 
After evaporation of the solvents, a saturated solution of NH3 in MeOH (30 mL) is added and 
stirring is continued overnight. Removal of the solvents and purification of the residue by 
flash chromatography (hexane/ethyl acetate/acetic acid, 300:100:1) affords hydroxy acid 13 as 
a colorless solid (585 mg, 74%). [ ]D20α = +9.8 (c = 1.50, CHCl3). 1H NMR (400 MHz, 
CD2Cl2): δ 7.75-7.68 (4H, m), 7.5-7.30 (21H, m), 4.94 (1H, AB, J = 11.0 Hz), 4.90 (1H, AB, 
J = 11.0 Hz), 4.82 (1H, AB, J = 11.0 Hz), 4.79 (1H, AB, J = 11.0 Hz), 4.72 (1H, AB, J = 11.0 
Hz), 4.58 (1H, AB, J = 11.0 Hz), 4.52 (1H, d, J = 7.8 Hz), 4.12 (1H, m), 3.88 (1H, d, J = 
11.4), 3.68 (2H, t, J = 6.5 Hz), 3.65-3.55 (2H, m), 3.42-3.37 (3H, m), 2.59 (1H, dd, J = 8.0, 
15.3 Hz), 2.52 (1H, dd, J = 3.3, 15.3 Hz), 1.61 (2H, m), 1.45-1.15 (24H, m), 1.05 (9H, s). 13C 
NMR (100 MHz, CD2Cl2): δ 175.0, 138.9, 138.8, 138.4, 135.6, 134.4, 129.6-127.6, 103.7, 
84.7, 82.4, 78.6, 78.2, 75.6, 75.5, 74.9, 74.8, 64.2, 62.5, 41.5, 36.1, 32.7, 29.9-29.5, 26.8, 
25.9, 25.4, 19.2. IR: 3440, 3068, 2926, 2853, 1711, 1497, 1454, 1391, 1354, 1095, 1093, 737, 
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699 cm-1. MS (ESI): m/z 995 ([M+Na]+). Anal. calcd. for C60H80O9Si: C 74.04, H 8.28, 
found C 74.18, H 8.19. 
Compound 15. KH (5 mg, 0.12 mmol) is added at 0 °C to a solution of compound 13 (59 mg, 
0.06 mmol) and 2-chloro-1,3-dimethylimidazolinium chloride 14 (25 mg, 0.15 mmol) in 
CH2Cl2 (3.5 mL) and the resulting mixture is stirred for 1 h at that temperature. DMAP (17 
mg, 14 mmol) is then introduced and stirring is continued for 15 h at ambient temperature. 
For work-up, the mixture is filtered through a pad of Celite, the filtrate is evaporated, and the 
residue is purified by flash chromatography (hexane/ethyl acetate, 10:1) to give the 
monomeric lactone 18 (12 mg, 21%) and the desired lactide 15 (41 mg, 71%) as colorless 
syrups each. Data of compound 18: [ ]D20α = +31.6 (c = 2.00, CHCl3). 1H NMR (400 MHz, 
CD2Cl2): δ 7.73-7.68 (4H, m), 7.5-7.25 (21H, m), 4.97 (1H, d, J = 11.2 Hz), 4.93 (1H, dd, J = 
11.7, 3.1 Hz), 4.83 (1H, s), 4.70 (2H, s), 4.67 (1H, d, J = 11.2 Hz), 4.63 (1H, d, J = 10.6 Hz), 
4.54 (1H, d, J = 11.6 Hz), 4.28 (1H, t, J = 10.1 Hz), 3.91 (1H, d, J = 11.7 Hz), 3.81 (1H, d, J = 
3.8 Hz), 3.78 (1H, m), 3.74 (1H, m), 3.73 (1H, dd, J = 3.8, 10.1 Hz), 3.69 (2H, t, J = 6.5), 
2.54 (1H, t, J = 11.3 Hz), 2.39 (1H, dd, J = 2.1, 11.3 Hz), 1.61 (4H, m), 1.40-1.20 (22H, m), 
1.06 (9H, s). 13C NMR (100 MHz, CD2Cl2): δ 174.1, 138.5, 137.7, 135.6, 134.3, 129.6-
127.6, 102.2, 84.2, 84.0, 81.2, 76.1, 75.1, 73.5, 72.9, 71.7, 64.1, 63.2, 43.6, 37.4, 32.7, 29.9-
29.5, 26.7, 25.9, 25.9, 19.1. IR: 2927, 2854, 1747, 1589, 1497, 1454, 1110, 1091, 738, 700 
cm-1. MS (ESI): m/z 977 ([M+Na]+). 
Data of lactide 15: [ ]D20α  = +26.0 (c = 2.00, CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.73-
7.68 (8H, m), 7.50-7.25 (42H, m), 4.96 (2H, d, J = 11.1 Hz), 4.92 (2H, d, J = 11.0), 4.82 (2H, 
d, J = 11.1 Hz), 4.78 (2H, d, J = 11.0 Hz), 4.73 (2H, d, J = 11.1 Hz), 4.55 (2H, d, J = 11.1 
Hz), 4.47 (2H, d, J = 7.9 Hz), 4.30 (2H, d, J = 11.3), 4.07-4.00 (4H, m), 3.68 (4H, t, J = 6.5 
Hz), 3.64 (2H, t, J = 8.9 Hz), 3.52 (2H, t, J = 9.8 Hz), 3.51 (2H, m), 3.41 (2H, dd, J = 7.9, 9.0 
Hz), 2.89 (2H, dd, J = 6.1, 16.0 Hz), 2.35 (2H, dd, J = 5.8, 16.0 Hz), 1.7-1.35 (8H, m), 1.40-
1.10 (44H), 1.04 (9H, s); 13C NMR (100 MHz, CD2Cl2): δ 171.4, 138.9, 138.8, 138.3, 135.6, 
134.4, 124.4-127.6, 105.3 (104.9 in CDCl3), 84.8, 82.3, 79.3, 77.8, 75.6, 74.9, 74.8, 72.4, 
64.2, 63.6, 41.6, 36.2, 32.7, 29.9-29.5, 26.8, 25.9, 25.4, 19.2. IR: 2927, 2854, 1737, 1589, 
1497, 1428, 1110, 1087, 1070, 737, 700 cm-1. MS (ESI) m/z 1931 ([M+Na]+). Anal. calcd. 
for C120H156O16Si: C 75.43, H 8.23, found C 75.27, H 8.21. 
Compound 16. A solution of compound 15 (450 mg, 0.236 mmol) and tetrabutylammonium 
fluoride trihydrate (158 mg, 0.50 mmol) in THF (5 mL) is stirred at ambient temperature for 
30 min. For work-up, the solvent is evaporated and the residue is purified by flash 
chromatography (hexane/ethyl acetate, 1:1) to give diol 16 as an amorphous solid (310 mg, 
92%). mp 129-131 °C. 1H NMR (CD2Cl2): δ 7.4-7.20 (30H, m), 4.98 (2H, d, J = 11.2 Hz), 
4.93 (2H, d, J = 11.1 Hz), 4.84 (2H, d, J = 11.2 Hz), 4.80 (2H, d, J = 11.1 Hz), 4.75 (2H, d, J 
= 11.2 Hz), 4.56 (2H, d, J = 11.2 Hz), 4.49 (2H, d, J = 7.9 Hz), 4.32 (2H, d, J = 11.3 Hz), 4.05 
(4H, m), 3.66 (2H, t, J = 8.9 Hz), 3.58 (4H, t, J = 6.6 Hz), 3.54 (2H, t, J = 9.5 Hz), 3.51 (2H, 
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dd, J = 9.5, 1.7 Hz), 3.43 (2H, dd, J = 7.9, 9.0 Hz), 2.90 (2H, dd, J = 6.0, 16.0 Hz), 2.37 (2H, 
dd, J = 5.9, 16.0 Hz), 1.7-1.45 (8H, m), 1.4-1.1 (44H). 13C NMR (CD2Cl2): δ 171.4, 138.9, 
138.8, 138.3, 128.4-127.6, 105.3 (104.9 in CDCl3), 84.8, 82.3, 79.2, 77.7, 75.6, 74.9, 74.8, 
72.4, 63.6, 62.9, 41.6, 36.2, 33.0, 29.8-29.6, 25.9, 25.4. MS (ESI): m/z 1455 ([M+Na]+). Anal. 
calcd. for C88H120O16: C 73.71, H 8.44, found C 73.80, H 8.31. 
Compound 17. A solution of diol 16 (360 mg, 0.25 mmol) in CH2Cl2 (3 mL) is treated with 
tert-butyldiphenylsilyl chloride (70 µL, 0.26 mmol), triethylamine (60 µL, 0.50 mmol) and a 
few crystals of DMAP at ambient temperature for 1 h. The solvent is evaporated and the 
residue is purified by flash chromatography (hexane/ethyl acetate, 2:1) to yield a mixture 
containing the disilylated derivative 15 (22%), the desired mono-silylated compound 17 (240 
mg, 52%), and recovered starting diol 16 (21%) which are separated by flash 
chromatography. Analytical and spectroscopic data of compound 17: [ ]D20α = +28.8 (c = 1.00, 
CHCl3). mp 74-75 °C. 1H NMR (400 MHz, CDCl3). δ 7.67-7.65, 7.37-7.23 (40H, m), 4.99-
4.53 (12H, 6AB), 4.46 (2H, d, J = 7.8 Hz), 4.34 (2H, dd, J = 1.8, 11.7 Hz), 3.99 (2H, m), 
3.67-3.62 (6H, m), 3.49 (2H, ddd, J = 1.9, 6.2, 9.7 Hz), 3.44 (2H, t, J = 8.7 Hz), 3.40 (2H, dd, 
J = 8.0, 9.1 Hz), 2.93 (2H, dd, J = 5.2, 15.9 Hz), 2.36 (2H, dd, J = 7.1, 15.9 Hz), 1.80-1.15 
(64H, m), 1.04 (9H, s). 13C NMR (100 MHz, CDCl3): δ 171.3, 138.4, 138.3, 137.8, 135.6, 
134.2, 129.4, 128.4-127.5, 104.9, 84.8, 82.3, 78.7, 77.8, 75.7, 75.0, 74.9, 72.2, 64.0, 63.5, 
63.0, 41.4, 35.9, 32.8, 32.6, 29.7-29.4, 26.9, 25.8, 25.7, 25.4, 19.2. IR: 3525, 3031, 2923, 
2852, 1732, 1717, 1068 cm−1. Anal. calcd. for C104H138O16Si: C 74.70, H 8.32, found C 
74.76, H 8.25. 
Compound 19. The synthesis of the (S)-enantiomer follows the same procedure as in case of 
(R)-6 using (S)-BINAP as the ligand, [ ]D20α = +7.1 (c = 1.00, CHCl3). HRMS (ESI): calcd. for 
C37H60O4Si (596.96): 597.4339, found 597.4338 ([M+H]+). 
Glycoside 20. TMSOTf (15 µL) is added to a solution of alcohol (S)-19 (500 mg, 0.83 mmol) 
and trichloroacetimidate 11 (800 mg, 1.25 mmol) in CH2Cl2 (20 mL) and CH3CN (20 mL) at 
–50 °C and the reaction mixture is stirred for 30 min before it is allowed to warm to ambient 
temperature. For work-up, the reaction is neutralised with Et3N, the solvents are evaporated 
and the residue is purified by flash chromatography (hexane/ethyl acetate, 15:1). The first 
compound to be eluded is the desired β-anomer 20 which is obtained as a colorless oil (570 
mg, 63%): [ ]D20α = +8.0 (c = 1.10, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.60-7.15 (m, 
25H), 4.93-4.53 (3AB, 6H), 4.50 (1H, d, J = 7.8 Hz), 4.32 (1H, d, J = 11.8 Hz), 4.38 (1H, dd, 
J = 4.8, 11.7 Hz), 4.10 (1H, m), 3.65 (2H, t, J = 6.6 Hz), 3.62 (1H, m), 3.49 (2H, m), 3.39 
(1H, dd, J = 7.8, 9.1 Hz), 2.59 (1H, dd, J = 6.3, 15.6 Hz), 2.39 (1H, dd, J = 6.5, 15.6 Hz), 2.01 
(3H, s) 1.60-1.24 (26 H, m), 1.41 (9H, s), 1.04 (9H, s). 13C NMR (100 MHz, CDCl3): δ 
170.7, 138.5, 138.4, 137.8, 135.6, 134.2, 129.4, 128.5, 128.3, 1283-128.1, 127.9, 127.8, 
127.5, 102.3, 84.8, 82.1, 80.7, 77.7, 76.1, 75.6, 74.9, 74.7, 72.7, 64.0, 63.3, 41.3, 35.4, 32.6, 
29.7-29.6, 29.4, 28.1, 26.9, 25.7, 25.0, 20.8, 19.2. IR: 2928, 2855, 1744, 1731, 1454, 1235, 
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1071 cm-1. MS (ESI): m/z 1093 ([M+Na]+). Anal. calcd. for C66H90O10Si: C 73.98, H 8.47, 
found C 73.85, H 8.45. 
The second fraction is the corresponding α-anomer (170 mg, 19%) which shows the 
following spectroscopic and analytical properties. Syrup, [ ]D20α = +34.6 (c = 0.75, CHCl3). 1H 
NMR (400 MHz, CDCl3): δ 7.80-7.20 (m, 25H), 4.96 (1H, d, J = 3.0 Hz), 4.99-4.54 (6H, 
3×AB), 4.27 (2H, m), 4.03-3.94 (2H, m), 3.65 (2H, t, J = 6.6 Hz), 3.65 (1H, dd, J = 3.7, 9.7 
Hz), 3.46 (1H, dd, J = 8.9, 10.1 Hz), 2.63 (1H, dd, J = 6.7, 15.5 Hz), 2.39 (1H, dd, J = 6.2, 
15.5 Hz), 2.00 (3H, s), 1.65-1.24 (26H, m), 1.42 (9H, s), 1.04 (9H, s). 13C NMR (100 MHz, 
CDCl3): δ 170.7, 138.7, 138.1, 135.5, 134.2, 129.4, 128.4-127.5, 95.8, 81.9, 80.6, 80.1, 77.4, 
75.6, 75.3, 74.2, 73.1, 68.8, 64.0, 63.1, 41.3, 33.6, 32.6, 29.7-29.6, 29.4, 28.1, 26.9, 25.8, 
24.9, 20.8, 19.2. IR: 2928, 2855, 1743, 1732, 1110 cm-1. MS (ESI): m/z 1093 ([M+Na]+). 
Anal. calcd. for C66H90O10Si: C 73.98, H 8.47, found C 73.82, H 8.51. 
Compound 23. Glycoside 20 (300 mg, 0.28 mmol) is treated with a saturated methanolic 
solution of ammonia (10 mL) overnight. All volatiles are then removed in vacuo and the 
residue is purified by flash chromatography (hexane/ethyl acetate, 10:1) to give alcohol 23 as 
a colorless syrup (240 mg, 83%): [ ]D20α = +7.0 (c = 0.75, CHCl3); 1H NMR (400 MHz, 
CDCl3): δ 7.75-7.20 (25H, m), 4.92-4.60 (6H, 3×AB), 4.54 (1H, d, J = 7.8 Hz), 4.14 (1H, m), 
3.83 (1H, dd, J = 2.7, 11.8 Hz), 3.69-3.61 (4H, m), 3.51 (1H, dd, J = 9.1, 9.5 Hz), 3.36 (2H, 
m), 2.57 (1H, dd, J = 6.6, 15.6 Hz), 2.38 (1H, dd, J = 6.3, 15.7 Hz), 1.85 (bs, 1H, OH), 1.60-
1.24 (26 H, m), 1.42 (9H, s), 1.04 (9H, s). 13C NMR (100 MHz, CDCl3): δ 170.8, 138.6, 
138.5, 138.0, 135.6, 134.2, 129.4, 129.0, 128.4, 128.3, 128.2, 128.1, 128.0, 127.8, 127.50, 
101.6, 84.7, 82.3, 80.8, 77.0, 75.7, 75.5, 75.0, 74.8, 74.9, 64.0, 62.2, 41.3, 35.2, 32.6, 29.7-
29.6, 29.4, 28.1, 26.9, 25.8, 25.1, 19.2. IR: 3480, 2927, 2855, 1729, 1367, 1091 cm-1. MS 
(ESI) m/z: 1051 ([M+Na]+). Anal. calcd. for C69H88O9Si: C 74.67, H 8.62, found C 74.88, H 
8.61. 
Hydroxy Acid 21. Trifluoroacetic acid (0.2 mL) is added to a solution of glycoside 23 (60 
mg, 0.06 mmol) in CH2Cl2 (2 mL) at 0 °C. The ice bath is removed and the solution is stirred 
at ambient temperature for 10 h. For work-up, the solvent is evaporated and the crude product 
is purified by flash chromatography (hexane/ethyl acetate/acetic acid, 300:100:1) to give 
compound 21 as a colorless syrup (20 mg, 35% yield). 1H NMR (400 MHz, CD2Cl2): δ 7.72-
7.68 (4H, m), 7.5-7.30 (21H, m), 4.89 (2H, d, J = 11.0 Hz), 4.85 (2H, d, J = 11.0 Hz), 4.80 
(1H, d, J = 11.0 Hz), 4.70 (1H, d, J = 11.3 Hz), 4.62 (1H, d, J = 11.3 Hz), 4.60 (1H, d, J = 7.8 
Hz), 4.19 (1H, m), 3.84 (1H, dd, J = 2.6, 11.4), 3.68 (2H, t, J = 6.5 Hz), 3.65-3.55 (2H, m), 
3.50 (1H, t, J = 9.0 Hz), 3.39 (1H, m), 3.36 (1H, dd, J = 7.9, 9.0 Hz), 2.64 (1H, dd, J = 7.4, 
16.0 Hz), 2.54 (1H, dd, J = 5.2, 16.0 Hz), 1.58 (2H, m), 1.45-1.2 (24H), 1.05 (9H, s). 13C 
NMR (100 MHz, CD2Cl2): δ 175.0, 138.9, 138.8, 138.5, 135.7, 134.4, 129.6-127.6, 101.7, 
84.7, 82.2, 78.0, 75.7, 75.56, 75.3, 74.9, 74.8, 64.2, 62.2, 39.6, 35.3, 32.7, 29.8-29.5, 26.8, 
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25.9, 25.3, 19.2. MS (ESI): m/z 995 ([M+Na]+). Anal. calcd. for C60H80O9Si: C 74.04, H 
8.28, found C 74.09, H 8.16. 
Macrodiolide 22. KH (2 mg, 0.05 mmol) is added to a solution of hydroxy acid 21 (20 mg, 
0.02 mmol) and 2-chloro-1,3-dimethylimidazolium chloride 14 (15 mg, 0.08 mmol) in 
CH2Cl2 (3 mL) at 0 °C and stirring is continued for 1 h. DMAP (12 mg, 0.09 mmol) is then 
introduced and the reaction is stirred for 15 h. For work-up, the mixture is filtered through a 
pad of Celite, the solvent is evaporated, and the residue is purified by flash chromatography 
(hexane/ethyl acetate, 10:1) to yield lactide 22 (8 mg, 41%) as a colorless syrup. 1H NMR 
(400 MHz, CD2Cl2): δ 7.66 (8H, m), 7.50-7.25 (42H, m), 4.92 (2H, d, J = 11.1 Hz), 4.86 (2H, 
d, J = 11.0 Hz), 4.85 (2H, d, J = 11.1 Hz), 4.77 (2H, d, J = 11.1 Hz), 4.67 (2H, d, J = 11.1 
Hz), 4.56 (2H, d, J = 11.1 Hz), 4.50 (2H, d, J = 7.8 Hz), 4.33 (2H, dd, J = 1.8, 11.3), 4.18 
(2H, m), 3.93 (2H, dd, J = 10.1, 11.3 Hz), 3.66 (2H, t, J = 9.0 Hz), 3.65 (4H, t, J = 6.5 Hz), 
3.62 (2H, dt, J = 1.8, 10.0, 10.0 Hz), 3.38 (2H, dd, J = 7.8, 9.0 Hz), 3.30 (2H, dd, J = 9.0, 10.0 
Hz, H-4), 2.85 (2H, dd, J = 3.9, 13.7 Hz), 2.36 (2H, dd, J = 10.9, 13.7 Hz), 1.6-1.5 (8H, m), 
1.40-1.10 (44H), 1.04 (s, 18H). 13C NMR (100 MHz, CD2Cl2): δ 170.4, 139.1, 138.9, 138.3, 
135.9, 134.6, 129.8-127.8, 100.3, 85.1, 82.4, 78.9, 75.9, 75.3, 75.0, 73.7, 73.3, 65.1, 64.4, 
39.7, 35.3, 33.0, 30.4-29.5, 27.0, 26.2, 24.8, 19.4. MS (ESI): m/z 1931 ([M+Na]+). 
Compound 25. To a solution of alcohol 23 (215 mg, 0.20 mmol), acid 24 (see below, 200 
mg, 0.24 mmol) and DMAP (32 mg, 0.26 mmol) in CH2Cl2 (5 mL) is added DIC (0.51 mmol, 
0.51 mL of a 1M solution in CH2Cl2) at 0 °C. The mixture is allowed to warm to ambient 
temperature while stirring overnight. Evaporation of the solvent left a syrup which is purified 
by flash chromatography (hexane/ethyl acetate, 15:1) to give ester 25 as a colorless oil (320 
mg, 83%). [ ]D20α = +8.4 (c = 1.00, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.70-7.20 (40H, 
m), 5.86-5.75 (1H, m), 5.04-4.52 (14H, m), 4.50 (1H, d, J = 7.8 Hz), 4.47 (1H, d, J = 7.8 Hz), 
4.34 (1H, d, J = 11.9 Hz), 4.22 (1H, dd, J = 4.6, 11.6 Hz), 4.12-4.05 (2H, m), 3.84-3.76 (2H, 
m), 3.64 (2H, t, J = 6.6 Hz), 3.62-3.58 (3H, m), 3.50-3.46 (2H, m), 3.38-3.31 (2H, m), 3.23 
(1H, m), 2.96 (1H, dd, J = 4.6, 16.1 Hz), 2.58 (1H, dd, J = 6.2, 15.4 Hz), 2.51 (1H, dd, J = 
8.4, 16.3 Hz), 2.39 (1H, dd, J = 6.4, 15.6 Hz), 2.04 (2H, m), 1.60-1.24 (50 H, m), 1.41 (9H, s), 
1.04 (9H, s), 0.88 (9H, s), 0.07 and 0.04 (2s). 13C NMR (100 MHz, CDCl3): δ 171.0, 170.7, 
139.2, 138.7, 138.6, 138.5, 137.8, 135.6, 134.2, 129.4, 128.5, 128.4-128.3, 128.1, 127.9, 
127.8, 127.7, 127.5-127.4, 114.07, 103.8, 102.3, 84.7, 82.6, 82.2, 80.7, 78.0, 77.5, 77.2, 76.0, 
75.5, 75.7, 75.6, 74.1, 74.9, 74.8, 74.7, 72.8, 64.0, 63.1, 62.1, 41.1, 40.1, 33.8, 35.4, 35.1, 
32.6, 29.9-29.4, 28.1, 26.9, 25.9, 25.3, 24.9, 19.2, 18.3, −5.0, −5.4. IR: 3066, 3031, 2926, 
2854, 1734, 1454, 1071 cm-1. MS (ESI) m/z: 1877 ([M+Na]+). Anal. calcd. for 
C115H162O16Si2: C 74.39, H 8.80, found C 74.51, H 8.87. 
Compound 26. A solution of compound 25 (200 mg, 0.11 mmol) in CH2Cl2 (10 mL) is 
treated with trifluoroacetic acid (1 mL) at ambient temperature for 30 min. All volatiles are 
then evaporated by repeated azeotropic distillation with toluene and the residue is purified by 
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flash chromatography (hexane/acetone, 9:1) to give hydroxy acid 26 as a colorless solid (140 
mg, 77%). mp 70-71 °C. [ ]D20α = +6.6 (c = 0.80, CHCl3). 1H NMR (400 MHz, CDCl3): δ 
7.70-7.20 (40H, m), 5.86-5.76 (1H, m), 5.01-4.45 (14H, m), 4.54 (1H, d, J = 7.7 Hz), 4.44 
(1H, d, J = 7.8 Hz), 4.39 (1H, dd, J = 2.3, 11.7 Hz), 4.22 (1H, m), 4.12 (1H, dd, J = 6.5, 11.7 
Hz), 4.08 (1H, m), 3.78 (1H, dd, J = 2.2, 12.1 Hz), 3.65 (2H, t, J = 6.6 Hz), 3.69-3.61 (2H, 
m), 3.57-3.52 (2H, m), 3.45-3.35 (5H, m), 2.70 (1H, dd, J = 7.5, 15.4 Hz), 2.60 (1H, dd, J = 
7.3, 15.9 Hz), 2.50 (1H, dd, J = 4.7, 15.9 Hz), 2.40 (1H, dd, J = 4.4, 15.4 Hz), 2.04 (2H, m), 
1.75-1.23 (50 H, m), 1.04 (9H, s). 13C NMR (100 MHz, CDCl3): δ 171.9, 173.6, 139.2, 
138.7, 138.4, 138.4, 137.9, 137.7, 135.6, 134.2, 129.4, 128.4-128.3, 128.0-127.8, 127.8-127.5, 
114.4, 103.5, 101.2, 84.8, 84.7, 82.3, 82.1, 78.3, 78.1, 77.8, 75.3, 75.3, 75.7, 75.0-74.9, 74.8, 
72.8, 64.0, 63.7, 62.3, 41.2, 39.3, 33.8, 35.8, 35.3, 32.6, 29.8-29.4, 29.2, 29.0, 26.9, 25.7, 
25.2, 25.1, 19.2. IR: 3515, 3065, 2921, 2852, 1956, 1728, 1697, 1453, 1087 cm-1. MS (ESI): 
m/z 1708 ([M+Na]+). 
Lactide 27. Triethylamine (16 µL, 0.120 mmol) is added to a solution of acid 26 (100 mg, 
0.06 mmol) in THF (5 mL) at ambient temperature. After 10 min, the mixture is treated with 
2,4,6-trichlorobenzoyl chloride (12 µL, 0.078 mmol) and stirring is continued for 2 h. The 
resulting mixture is diluted with toluene (50 mL) and added dropwise over a period of 3 h to a 
refluxing solution of DMAP (150 mg, 1.20 mmol) in toluene (100 mL). Once the addition is 
complete, reflux is continued for 1 h prior to evaporation of all volatiles and flash 
chromatography of the residue (hexane/acetone, 95:5). This affords macrolactone 27 as a 
colorless solid (88 mg, 89%). mp 90-91 °C. [ ]D20α = +16.4 (c = 1.00, CHCl3); 1H NMR (400 
MHz, CDCl3): δ 7.70-7.22 (40H, m), 5.86-5.76 (1H, m), 5.01-4.54 (14H, m), 4.56 (1H, dd, J 
= 2.4, 11.3 Hz), 4.51 (1H, d, J = 7.9 Hz), 4.45 (1H, d, J = 7.7 Hz), 4.34 (1H, dd, J = 2.0, 11.2 
Hz), 4.17 (1H, m), 4.09 (1H, dd, J = 9.6, 11.1 Hz), 4.01 (1H, m), 3.81 (1H, dd, J = 9.1, 11.5 
Hz), 3.65 (2H, t, J = 6.6 Hz), 3.70-3.60 (2H, m), 3.60-3.51 (2H, m), 3.43 (1H, dd, J = 8.4, 8.6 
Hz), 3.39 (1H, dd, J = 8.2, 9.2 Hz), 3.34 (1H, dd, J = 9.1, 9.4 Hz), 3.27 (1H, t, J = 9.3 Hz), 
3.40 (1H, dd, J = 3.7, 15.3 Hz), 2.86 (1H, dd, J = 4.7, 13.9 Hz), 2.52 (1H, dd, J = 10.7, 15.3 
Hz), 2.32 (1H, dd, J = 10.4, 13.7 Hz), 2.02 (2H, m), 1.75-1.19 (50H, m), 1.04 (9H, s). 13C 
NMR (100 MHz, CDCl3): δ 170.5, 170.4, 139.2, 138.5, 138.3, 138.2, 137.7, 137.4, 135.6, 
134.2, 129.4, 128.5, 128.4, 128.4-128.3, 128.1, 128.0, 127.8-127.5, 114.1, 104.5, 99.1, 84.9, 
84.6, 82.2, 82.1, 78.5, 78.5, 78.2, 75.8, 75.6, 75.2, 75.1, 74.8, 73.1, 72.6, 72.4, 64.5, 64.0, 
63.6, 41.4, 39.2, 33.8, 35.3, 34.3, 32.6, 29.8-29.4, 29.2, 29.9, 26.9, 25.8, 25.1, 24.8, 19.2. IR: 
3066, 3030, 2923, 2852, 1882, 1734, 1497, 1071 cm-1. MS (ESI): m/z 1689 ([M+Na]+). 
Compound 30. Zinc chloride (1.5 eq. of a 1M solution in diethyl ether) is added to a solution 
of the (R)-2-hexanol (152 µL, 1.0 mmol) and the 1,2-anhydro glucose derivative 293 (400 mg, 
1.0 mmol) in dry THF (10 mL) at –78 °C. The reaction is allowed to reach ambient 
temperature and stirring is continued overnight. The reaction is then diluted with MTBE and 
                                                 
3
 Belluci, G.; Chiappe, C.; D’Andrea, F. Tetrahedron: Asymmetry 1995, 6, 221-230. 
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washed with water and brine. Filtration through short silica gel column (hexan-ethyl acetate, 
4:1) affords glycoside 30 as a colorless syrup (160 mg, 32%). [ ]D20α = −12.1 (c =1.50, CHCl3). 
1H NMR (400 MHz, CHCl3): δ 7.38-7.18 (15H, m), 4.96-4.53 (6H, 3AB), 4.29 (1H, d, J = 
7.6 Hz), 3.88-3.80 (1H, m), 3.73 (1H, dd, J = 2.0, 10.9 Hz), 3.68 (1H, dd, J = 4.7, 10.8 Hz), 
3.62-3.42 (4H, m), 2.35-2.20 (1H, bs), 1.67-1.58 (1H, m), 1.50-1.25 (5H, m), 1.16 (3H, d, J = 
6.2 Hz), 0.89 (3H, bt, J = 6.9 Hz). 13C NMR (100 MHz, CHCl3): δ 138.7, 138.3, 138.2, 
128.3-127.5, 100.7, 84.6, 77.7, 75.3, 75.0, 74.9, 74.9, 74.9, 74.7, 73.5, 69.1, 36.8, 27.6, 22.6, 
19.7, 14.0. IR: 3457, 2956, 2869, 1454, 1108, 1063 cm-1. HRMS (EI): calcd. for C33H42O6: 
534.2981, found 534.2980. 
Compound 31. To a stirred solution of 30 (40 mg, 0.075 mmol) in dry DMF (5 mL) are 
added NaH (8 mg, 0.30 mmol, 4 eq.) and methyl iodide (20 µL, 0.30 mmol, 4 eq.) at 0 °C and 
the resulting mixture is stirred at ambient temperature for 1 h. For work-up, residual sodium 
hydride is destroyed with a few drops of methanol. The reaction mixture is diluted with 
MTBE, washed with water and brine, the organic phase is dried and evaporated. The crude 
product is filtered through a short column of silica (hexane/ethyl acetate, 10:1) to give the 
corresponding 2’-O-methyl ether derivative which shows the following spectroscopic 
properties: 1H NMR (400 MHz, CHCl3): δ 7.37-7.17 (15 H, m), 4.92-4.52 (6H, 3AB), 4.33 
(1H, d, J 7.8 Hz), 3.72 (1H, dd, J 1.9, 10.9 Hz), 3.66 (1H, dd, J 5.0, 10.9 Hz), 3.60 (3H, s), 
3.58-3.49 (2H, m), 3.46-3.38 (1H, m), 3.12 (1H, t, J = 7.9 Hz), 1.70-1.25 (6H, m), 1.19 (3H, 
d, J = 6.2 Hz), 0.89 (bt, 3H, J = 6.9 Hz). 13C NMR (100 MHz, CHCl3): δ 138.9, 138.4, 138.3, 
128.3-127.4, 101.6, 85.1, 84.3, 77.8, 75.4, 75.3, 74.9, 73.5, 69.2, 60.4, 37.0, 27.5, 22.7, 19.6, 
14.1.  
To a solution of this methyl ether in ethyl acetate (1 mL) and ethanol (2 mL) is added Pd-C 
(10%, 10 mg) and the resulting suspension is vigorously stirred under an atmosphere of H2 
for 12 h. The mixture is filtered through a pad of Celite and the filtrate is concentrated to give 
compound 31 (27 mg, 66 %) as a white solid: mp 64-65 °C. [ ]D20α = −31.0 (c = 0.60, MeOH). 
1H NMR (400 MHz, pyridine-d5): δ 4.78 (1H, d, J = 7.8 Hz), 4.48 (1H, dd, J = 2.5, 11.7 Hz), 
4.30 (1H, dd, J = 5.4, 11.7 Hz), 4.18-4.05 (2H, m), 4.02-3.96 (1H, m), 3.85-3.79 (1H, m), 
3.74 (3H, s), 3.38 (1H, t, J = 8.1 Hz), 1.70-1.60 (1H, m), 1.50-1.40 (1H, m), 1.45-1.20 (4H, 
m), 1.19 (3H, d, J = 6.1 Hz), 0.79 (3H, t, J = 7.3 Hz). 13C NMR (100 MHz, pyridine-d5): δ 
101.9, 85.1, 78.1, 77.7, 74.2, 71.8, 62.8, 60.6, 37.4, 27.7, 23.0, 19.6, 14.2. IR: 3334, 2932, 
1074 cm-1. HRMS (EI) calcd. for (C13H26O6+H): 279.1807, found 279.1806 ([M+H]+). 
Compound 32. Prepared as described above using (S)-2-hexanol (36%). [ ]D20α = −17.3 (c = 
1.20, CHCl3). 1H NMR (400 MHz, CHCl3): δ 7.38-7.17 (15H, m), 4.96-4.35 (6H, 3AB), 4.30 
(1H, d, J = 7.4 Hz), 3.75-3.53 (7H, m), 2.40-2.20 (1H, bs), 1.65-1.55 (1H, m), 1.50-1.25 (5H, 
m), 1.27 (3H, d, J = 6.2 Hz), 0.89 (3H, bt, J = 6.8 Hz). 13C NMR: δ 138.7, 138.3, 138.2, 
128.3-127.5, 102.5, 84.6, 77.7, 77.2, 75.1, 75.0, 74.9, 73.4, 69.1, 34.4, 27.6, 22.7, 21.7, 14.0. 
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IR: 3359, 2931, 1724, 1703, 1453, 1059 cm-1. HRMS (EI) calcd. for C33H42O6 m/z 
534.2981; found 534.2978. 
Compound 33. NaH (8 mg, 0.30 mmol, 4 eq.) and methyl iodide (20 µL, 0.30 mmol, 4 eq.) 
are added to a stirred solution of compound 32 (40 mg, 0.075 mmol) in DMF (5 mL) at 0 °C. 
After stirring for 1 h, the remaining sodium hydride is destroyed with a few drops of 
methanol. The reaction mixture is diluted with MTBE, the organic layer is washed with water 
and brine, dried and evaporated. The crude product is passed through a short column of silica 
(hexane/ethyl acetate, 10:1) to give the corresponding 2’-O-methyl ether derivative which 
shows the following spectroscopic properties: 1H NMR (400 MHz, CHCl3): δ 7.32-7.24 (15 
H, m), 4.92-4.50 (6H, 3AB), 4.33 (1H, d, J = 7.8 Hz), 3.70 (1H, m), 3.65-3.63 (1H, m), 3.60 
(3H, s), 3.55-3.48 (2H, m), 3.45-3.40 (1H, m), 3.13 (1H, t, J 7.9 Hz), 1.63-1.58 (1H, m), 1.49-
1.25 (5H, m), 1.27 (3H, d, J 6.2 Hz), 0.90 (3H, bt, J = 6.9 Hz). 13C NMR (100 MHz, CHCl3): 
δ 138.8, 138.3, 138.2, 128.3-127.4, 103.4, 85.1, 84.4, 77.8, 77.5, 75.5, 74.9, 74.7, 73.4, 69.3, 
60.6, 36.5, 27.4, 22.7, 21.8, 14.0.  
To a solution of this methyl ether in ethyl acetate (1 mL) and ethanol (2 mL) is added Pd-C 
(10%, 10 mg) and the resulting suspension is vigorously stirred under H2 for 12 h. The 
mixture is filtered through a pad of Celite and the filtrate is concentrated to give the product 
33 (30 mg, 70%) as a white solid: mp 46-47 °C. [ ]D20α  = −26.2 (c = 1.00, MeOH). 1H NMR 
(400 MHz, pyridine-d5): δ 4.49 (1H, d, J = 7.8 Hz), 4.48 (1H, dd, J = 2.5, 11.6 Hz), 4.30 (1H, 
dd, J = 5.4, 11.6 Hz), 4.19-4.05 (2H, m), 3.93-3.89 (1H, m), 3.83-3.80 (1H, m), 3.93-3.89 
(1H, m), 3.83-3.80 (1H, m), 3.76 (3H, s), 3.38 (1H, t J = 8.5 Hz), 1.70-1.62 (1H, m), 1.50-
1.20 (5H, m), 1.30 (3H, d, J = 6.2 Hz), 0.84 (3H, t, J = 7.2 Hz). 13C NMR (100 MHz, 
pyridine-d5): δ 103.7, 85.3, 78.1, 77.8, 76.3, 71.7, 62.8, 60.7, 36.7, 27.6, 23.0, 22.0, 14.2. IR: 
3365, 2932, 1379, 1172, 1080, 1028 cm-1. HRMS (EI) calcd. for (C13H26O6+H): 279.1807, 
found 279.1809 ([M+H]+). 
4-Bromo-1-(tert-butyldimethylsilyloxy)butane (34). A solution of 4-bromo-1-butanol4 (6.1 
g, 40 mmol), tert-butyldimethylsilyl chloride (7.2 g, 48 mmol), triethylamine (11.1 mL, 80 
mmol) and DMAP (50 mg) in dry CH2Cl2 (50 mL) is stirred at ambient temperature 
overnight. The solvent is evaporated and the residue is purified by flash chromatography 
(hexane/ethyl acetate, 6:1) to give compound 34 as a colorless oil (8.5 g, 80%). All analytical 
and spectroscopic data are in agreement with those previously reported in the literature.5 
(6R)-6-O-Benzyl-1-O-(tert-butyldimethylsilyl)-1,6-heptanediol (35). Magnesium turnings 
(365 mg, 15 mmol) are activated overnight with a few crystals of iodine under Ar before they 
are suspended in THF (10 mL). A solution of bromobutane 34 (4.0 g, 15 mmol) in THF (5 
mL) is slowly added to this suspension and the resulting mixture is refluxed for 2 h. The 
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  Tauh, P.; Fallis, A. G.; J. Org. Chem., 1999, 64, 6960. 
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Grignard reagent thus obtained is cooled to –40 °C and diluted with THF (50 mL). 
CuCl(COD) (150 mg, 0.7 mmol) is introduced before a solution of (R)-propenoxide (0.5 mL, 
7.0 mmol) in THF (5 mL) is added dropwise and the resulting mixture is stirred for 3 h while 
the temperature is allowed to rise to –10 °C. For work-up, the reaction is quenched with sat. 
aq. NH4Cl, diluted with MTBE and successively washed with aq. sat. NH4Cl and brine. The 
organic phase is dried and concentrated and the crude product is purified by flash 
chromatography (hexane/ethyl acetate, 4:1) to give desired alcohol (2.3 g, 70%) as a colorless 
oil which shows the following spectroscopic properties: [ ]D20α = −4.7 (c = 1.30, CHCl3). 1H 
NMR (300 MHz, CDCl3): δ 3.76 (1H, m), 3.56 (2H, t, J = 6.5 Hz), 1.53-1.27 (9H, m), 1.14 
(3H, d, J = 6.1 Hz), 0.85 (9H, s), 0.05, 0.01 (6H, 2s). 13C NMR (75 MHz, CDCl3): δ 68.1, 
63.2, 39.4, 32.8, 25.9, 25.8, 25.6, 23.5, 18.4, −5.25. IR: 3356, 2930, 2858, 1472, 1255, 1099, 
836 cm−1. HRMS (ESI): calcd. for (C13H31O2Si+H): 247.2093, found 247.2094 ([M+H]+).  
To a stirred solution of this alcohol (1.6 g, 6.94 mmol) in DMF (30 mL) are successively 
added NaH (340 mg, 14.0 mmol) and benzyl bromide (1.2 mL, 10 mmol) at 0 °C and the 
resulting mixture is stirred overnight. Excess NaH is destroyed by adding a few drops of 
methanol before the reaction mixture is diluted with MTBE, washed with water and brine. 
The organic layers are dried and evaporated and the residue is purified by flash 
chromatography (hexane/ethyl acetate, 50:1) to give product 35 (1.6 g, 73%) as a colorless 
oil. [ ]D20α = −12.1 (c = 1.08, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.28 (5H, m), 4.48 (2H, 
AB, J = 11.7, 33.0 Hz), 3.49 (2H, t, J = 6.5 Hz), 3.47 (1H, m), 1.60-1.22 (8H, m), 1.14 (3H, 
d, J = 6.2 Hz), 0.84 (9H, s), 0.01, 0.00 (6H, 2s). 13C NMR (75 MHz, CDCl3): δ 139.2, 
128.29-127.35, 74.9, 70.3, 63.2, 36.7, 32.8, 25.9, 25.8, 25.3, 19.6, 18.4, −5.24. IR: 2930, 
2857, 1471, 1387, 1255, 1097 cm−1. HRMS (ESI): calcd. for (C20H37O2Si+H): 337.2562, 
found 337.2561 ([M+H]+). 
(6R)-6-O-Benzyl-1,6-heptanediol (36). A solution of compound 35 (1.30 g, 3.86 mmol) and 
tetra-n-butylammonium fluoride trihydrate (1.26 g, 4.0 mmol) in THF (30 mL) is stirred at 
ambient temperature for 30 min. Evaporation of the solvent followed by flash 
chromatography (hexane/ethyl acetate, 2:1) of the residue affords alcohol 36 as a colorless oil 
(800 mg, 93%). [ ]D20α = −22.6 (c = 1.50, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.28 (5H, 
m), 4.48 (2H, AB, J = 11.8 Hz), 3.64 (2H, t, J = 6.6 Hz), 3.50 (1H, m), 1.65-1.32 (9H, m), 
1.18 (3H, d, J = 6.1 Hz). 13C NMR (75 MHz, CDCl3): δ 139.1, 128.3-127.3, 74.7, 70.3, 62.9, 
36.6, 32.7, 25.8, 25.3, 19.6. IR: 3383, 3088, 2933, 2860, 1454, 1374, 1068 cm−1. HRMS 
(ESI): calcd. for (C14H23O2+H): 223.1698, found 223.1698 ([M+H]+). 
(6R)-6-O-Benzyl-1-iodo-6-heptanol (37). I2 (3.20 g, 12.60 mmol) is added to a solution of 
triphenylphosphine (1.65 g, 6.30 mmol) and imidazole (860 mg, 12.60 mmol) in acetonitrile 
(20 mL) and THF (5 mL) at 0 °C. The mixture is stirred for 15 min at this temperature before 
a solution of alcohol 36 (700 mg, 3.15 mmol) in acetonitrile (5 mL) is added and the resulting 
mixture is stirred for 2 h. Dilution with MTBE, successive washing of the organic layer with 
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aq. Na2S2O3, water and brine, followed by flash chromatography (hexane/ethyl acetate, 50:1) 
of the residue gives iodide 37 as a pale yellow oil (930 mg, 89%): [ ]D20α = −12.9 (c = 1.00, 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.33 (5H, m), 4.49 (2H, AB, J = 11.8 Hz), 3.51 (1H, 
m), 3.17 (2H, t, J = 7.0 Hz), 1.82 (2H, m), 1.65-1.55 (2H, m), 1.50-1.30 (6H, m), 1.19 (3H, d, 
J = 6.1 Hz). 13C NMR (100 MHz, CDCl3): δ 139.1, 128.3-127.4, 74.6, 70.3, 36.6, 33.5, 30.5, 
24.4, 19.6, 7.07. IR: 3029, 2932, 2858, 1453, 1373, 1208, 1094, 1067 cm−1. HRMS (ESI): 
calcd. for C14H21OI: 332.0637, found 332.0638. 
Preparation of the Dialkylzinc Compound 38.6 A Schlenk-flask is charged with iodide 37 
(1.0 g, 3.0 mmol), CuCN (9 mg, 0.1 mmol) and diethylzinc (1.2 mL, 12 mmol) and the 
resulting mixture is stirred for 10 days at 50 °C under Ar. The progress of the reaction can be 
monitored by GC/MS or TLC control of hydrolyzed samples. Excess diethylzinc and the 
resulting ethyl iodide are pumped off in high vacuo within 2 h at ambient temperature. The 
dialkylzinc reagent 38 thus formed is dissolved in toluene (9 mL) and the resulting stock 
solution (1 mL contains ca. 0.15 mmol dialkylzinc derivative) is ready for use. 
Compound 40. A flame-dried flask is charged with trans-(1R,2R)-bis(trifluoromethyl-
sulfonylamido)-cyclohexane (39) (25 mg, 0.06 mmol), toluene (2 mL) and Ti(OiPr)4 (180 µL, 
0.6 mmol) and the mixture is stirred at 40 °C for 30 min under Ar. After being cooled to –50 
°C, a solution of the zinc reagent 38 (0.6 mmol) is added before a solution of dodecanal (100 
µL, 0.44 mmol) in toluene (2 mL) is introduced and the resulting mixture is allowed to slowly 
warm (1 h) to –20 °C. The reaction is quenched by adding aq. sat. NH4Cl before it is diluted 
with MTBE and washed with 1N HCl, water and brine. The organic phase is dried (Na2SO4) 
and concentrated and the residue is purified by flash chromatography (hexane/ethyl acetate, 
9:3) to yield alcohol 40 as a colorless oil (112 mg, 65%). [ ]D20α  = −9.3 (c = 1.10 in CHCl3). 
1H NMR (400 MHz, CDCl3): δ 7.35-7.23 (10H, m), 4.50 (2H, AB), 3.58-3.55 (1H, m), 3.52-
3.47 (1H, m), 1.58-1.20 (36H, m), 1.18 (3H, d, J = 6.1 Hz), 0.87 (3H, t, J = 6.7 Hz).
 
13C 
NMR (100 MHz, CDCl3): δ 139.2, 129.5, 128.3, 127.6, 127.3, 74.9, 74.8, 72.0, 70.3, 37.5, 
37.4, 36.6, 31.9, 29.7-29.3, 25.7, 25.6, 25.5, 22.6, 19.6. HRMS (EI): calcd. for 
(C26H46O2+H): 391.3576, found 391.3578 ([M+H]+). 
3,4,6-Tri-O-benzyl-2-O-methyl-α-D-glucopyranose trichloroacetimidate (41). NaH (15 
mg, 0.6 mmol) is added to a solution of 3,4,6-tri-O-benzyl-2-O-methyl-α-D-glucopyranose7 
(465 mg, 1.0 mmol) in CH2Cl2 (10 mL) and trichloroacetonitrile (0.5 mL). After 1 h the 
mixture is filtered through a pad of Celite, the filtrate is evaporated and the residue is purified 
by flash chromatography (hexane/ethyl acetate, 4:1) to give compound 41 as a pale yellow oil 
(900 mg, 69%). [ ]D20α = +56.8 (c = 0.95, CHCl3). 1H NMR (400 MHz, CDCl3): δ 8.60 (1H, 
s), 7.31-7.26 (15H, m), 6.57 (1H, d, J = 3.5 Hz), 4.95-4.46 (6H, 3AB), 3.98 (1H, m), 3.97 
                                                 
6
  Rozema, M.J., Eisenberg, Ch., Lütjens, H., Ostwald, R., Belyk, K., Knochel, P. Tetrahedron Lett. 
1993, 34, 3115 
7
  Srivasteva, V.K., Schuerch, C. Tetrahedron Lett. 1979, 3269. 
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(1H, t, J = 9.3 Hz), 3.80-3.76 (2H, m), 3.68 (1H, dd, J = 1.9, 10.8 Hz), 3.55 (1H, dd, J = 3.5, 
9.6 Hz), 3.50 (3H, s). 13C NMR (100 MHz, CDCl3): δ 161.4, 138.7, 138.1, 137.9, 128.4-
127.5, 94.0, 81.7, 81.3, 76.7, 75.4, 75.3, 73.4, 73.1, 68.1, 58.9. IR: 3338, 2926, 1734, 1671, 
1074 cm−1. MS (ESI): 630 ([M+Na]+). HRMS (EI) calcd. 607.12952, found 607.12960. 
Compound 42. Alcohol 40 (60 mg, 0.15 mmol) and trichloroacetimidate 41 (140 mg, 0.225 
mmol, 1.5 eq.) are dissolved in CH2Cl2 and CH3CN (3 mL each) and the resulting solution is 
cooled to –50 °C. TMSOTf (5 µL) is added and the mixture is stirred 30 min at that 
temperature. After neutralisation with triethylamine and evaporation of the solvents, the 
residue is purified by flash chromatography (hexane/ethyl acetate, 4:1) to give glycoside 42 as 
a viscous oil (80 mg, 92%). [ ]D20α = −16.2 (c = 0.80, CHCl3); 1H NMR (400 MHz, CDCl3): 
δ  7.37-7.17 (20H, m), 4.92-4.40 (8H, 4AB), 4.31 (1H, d, J = 7.8 Hz), 3.72-3.65 (2H, m), 
3.65-3.58 (1H, m), 3.59 (3H, s), 3.55-3.50 (2H, m), 3.48-3.42 (1H, m), 3.42-3.38 (1H, m), 
3.13-3.08 (1H, m), 1.62-1.22 (30H, m), 1.15 (3H, d, J = 6.1 Hz), 0.88 (3H, t, J = 6.8 Hz).13C 
NMR: 139.2, 138.9, 135.5, 138.3, 128.3-127.3, 102.7, 85.2, 84.5, 80.2, 77.9, 75.5, 74.9, 73.5, 
70.2, 69.3, 60.6, 36.7, 34.9, 34.0, 31.9, 29.9-29.3, 25.5, 25.2, 25.0, 22.7, 19.6, 14.1. IR: 2926, 
2854, 1454, 1358, 1086 cm-1. HRMS (EI) calcd. for (C54H76O7+H): 837.56693, found 
837.56741 ([M+H]+). 
Compound 43. Prepared as described above using trans-(1S,2S)-bis(trifluoromethyl-
sulfonylamido)-cyclohexane as a catalyst in the dialkylzinc addition reaction. Viscous oil (80 
mg, 91%). [ ]D20α  = −17.2 (c = 0.95, CHCl3). 1H NMR (400 MHz, CDCl3): δ  7.27-7.07 (20H, 
m), 4.92-4.40 (8H, 4AB), 4.31 (1H, d, J = 7.8 Hz), 3.72-3.65 (2H, m), 3.65-3.58 (1H, m), 3.59 
(3H, s), 3.55-3.50 (2H, m), 3.48-3.42 (1H, m), 3.42-3.38 (1H, m), 3.13-3.08 (1H, m), 1.62-
1.22 (30H, m), 1.18 (3H, d, J = 6.1 Hz), 0.88 (3H, t, J = 6.8 Hz).13C NMR (100 MHz, 
CDCl3): 139.2, 138.9, 135.5, 138.3, 128.3-127.3, 103.0, 85.2, 84.5, 80.3, 77.9, 75.5, 74.8, 
73.6, 70.3, 69.3, 60.6, 36.7, 34.9, 34.0, 31.9, 29.9-29.3, 25.5, 25.2, 25.0, 22.7, 19.6, 14.1. IR: 
2926, 2854, 1454, 1358, 1086 cm-1. HRMS calcd. for (C54H76O7+H): 837.56693, found 
837.56701 ([M+H]+). 
Compound 47. To a solution of diisopropylamine (22 mL, 157 mmol) in THF (200 mL) is 
slowly added n-BuLi (1.6 M in hexane, 98 mL, 157 mmol) at 0 °C. After stirring at 0 °C for 
30 min the solution is cooled to –78 °C. Freshly distilled cycloheptanone (18.4 mL, 156 
mmol) is added dropwise over 60 min and the resulting mixture is stirred for 30 min at –78 °C 
prior to the addition of MeI (13 mL, 209 mmol). The cooling bath is removed and the solution 
is allowed to reach ambient temperature while stirring for 15 h. The reaction is quenched with 
sat. aq. NH4Cl and CH2Cl2, the organic layer is successively washed with aq. HCl (0.1 M) 
and sat. aq. NaHCO3 and then dried over MgSO4, the solvent is evaporated and the product is 
purified by distillation (64 °C, 10 mbar) to give 2-methylcycloheptanone 47 (16.5 g, 84%). 1H 
NMR (300 MHz, CDCl3): δ 2.60 (1H, m), 2.47 (2H, m), 1.9-1.75 (4H, m), 1.74-1.25 (4H, m), 
1.06 (3H, d, J = 6.9 Hz). 13C NMR (75 MHz, CDCl3): δ 216.6, 46.6, 42.6, 33.3, 29.8, 28.6, 
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24.5, 17.6. MS (GC-EI) m/z 126, 111, 98, 93, 83, 69, 55, 41, 39, 27. These data are consistent 
with those previously reported in the literature.8 
Compound 48. A mixture containing 2-methylcycloheptanone (47) (16.3 g, 114 mmol) and 
an aq. suspension of m-CPBA (70-75%, 48 g, ca. 194-208 mmol) in CH2Cl2 (300 mL) is 
refluxed for 20 h. The reaction is quenched with sat. aq. NaHCO3, the organic layer is washed 
twice with sat. aq. Na2S2O3 and is dried over Na2SO4. Evaporation of the solvent followed 
by distillation of the residue (77 °C, 9.10-1 mbar) affords lactone 48 (13.54 g, 74%). This 
product contains traces of an unidentified by-product but can be used in the next step without 
further purification. An analytically pure sample is obtained by flash chromatography on 
silica gel (ethyl acetate/hexanes, 1:10) which exhibits the following spectroscopic properties: 
1H NMR (300 MHz, CDCl3): δ 4.75 (1H, m), 2.54 (2H, m), 1.95-1.40 (8H, m), 1.34 (3H, d, J 
= 6.9 Hz). 13C NMR (75 MHz, CDCl3): δ 176.6, 74.9, 38.9, 32.3, 28.8, 26.3, 24.0, 21.6. 
These data are consistent with those previously reported in the literature.9 
Compound 49. Porcine liver esterase (PLE SIGMA, 300 mg, 19U/mg) is added to a 
vigorously stirred solution of lactone 48 (4.0 g, 28.1 mmol) in aq. NaH2PO4-buffer (100 mM, 
50 mL). The pH-value of 7.2 is maintained throughout the reaction by an autotitrator (Mettler 
Toledo DL50) by adding aq. NaOH (2M) to the mixture. After a conversion of 40% 
(corresponding to the addition of 5.6 mL of the NaOH solution) Celite is added, the resulting 
mixture is stirred for 2 min, the Celite is filtered off and the aqueous filtrate is extracted with 
EtOAc. The combined organic layers are dried over Na2SO4 and evaporated to give 
enantiomerically enriched (S)-48. The remaining aqueous phase is acidified to pH = 2 by 
adding aq. HCl (2M) and is then repeatedly extracted with ethyl acetate. The combined 
organic phases are dried over Na2SO4 and evaporated to give enantiomerically pure (R)-7-
hydroxyheptanoic acid (49) (1.7 g, ee = 95%). [ ]D20α = +11.7 (c = 2.00, CHCl3). 1H NMR 
(300 MHz, CDCl3): δ 6.06 (2H, bs), 3.81 (1H, m), 2.35 (2H, t, J = 7.4 Hz), 1.65 (2H, m), 
1.55-1.20 (6H, m), 1.34 (3H, d, J = 6.2 Hz). 13C NMR (75 MHz, CDCl3): δ 179.1, 68.2, 38.9, 
34.0, 29.0, 25.3, 24.6, 23.4. These data are consistent with those previously reported. 9  
Compound 51. Carbonyl diimidazole (2.68 g, 16.5 mmol) is added to a solution of (R)-7-
hydroxyheptanoic acid 49 (1.97 g, 12.2 mmol) in THF (50 mL) at 0 °C and the resulting 
mixture is stirred for 4 h. After that time, the magnesium salt 50 (4.0 g, 12.7 mmol)10 is 
introduced, the cooling bath is removed, and the reaction is stirred for 10-15 h. For work-up, 
the solvent is evaporated and the residue is re-dissolved in CH2Cl2. The organic phase is then 
successively washed with water and sat. aq. NaHCO3, is dried over Na2SO4 and evaporated. 
A solution of the resulting syrup in THF (30 mL) is treated with aq. NaOH (2M, 4 mL) for 90 
                                                 
8
  (a) Liu, H.-J.; Wang, D.-X.; Kim, J. B.; Browne, E. N. C.; Wang, Y. Can. J. Chem. 1997, 75, 899; 
(b) Dave, V.; Warnhoff, E. W. J.Org.Chem. 1983, 48, 2590. 
9
  Fouque, E.; Rousseau, G. Synthesis 1989, 661. 
10
 Brooks, D. W.; Lu, L. D.; Masamune, S. Angew. Chem. 1979, 91, 76. 
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min before adding sat. aq. NH4Cl (20 mL) and CH2Cl2 (50 mL). The organic phase is dried 
over Na2SO4, the solvent is evaporated and the residue is purified by flash chromatography 
(hexane/ethyl acetate, 4:1) to give product 51 as a colorless oil (2.22 g, 74%). [ ]D20α = −6.2 (c 
= 1.08, CHCl3). 1H NMR (300 MHz, CDCl3): δ 5.05 (1H, m), 3.78 (1H, m), 3.39 (2H, s), 
2.54 (2H, t, J = 7.3 Hz), 1.61 (2H, m), 1.50-1.25 (6H, m), 1.25 (6H, d, J = 6.2 Hz), 1.17 (3H, 
d, J = 6.2 Hz). 13C NMR (75 MHz, CDCl3): δ 203.0, 166.9, 69.0, 67.9, 49.7, 42.9, 39.1, 29.0, 
25.5, 23.5, 23.4, 21.8. IR: 3442, 2979, 2934, 2859, 1736, 1713, 1643, 1466, 1375, 1312, 1269, 
1106 cm−1. HRMS (EI): m/z calcd. 245.175283, found 245.175194. 
Compound 52. A solution of [RuCl2(COD)]n (28 mg, 0.10 mmol) and (R)-BINAP (72 mg, 
0.12 mmol) in toluene (6 mL) and Et3N (0.2 mL, 0.15 mmol) is stirred for 4 h at 140 °C. The 
solvent is removed and THF (15 mL) is added. This catalyst solution is added to a solution of 
compound 51 (1.71 g, 7.0 mmol) in MeOH (40 mL) and the resulting mixture is stirred under 
an atmosphere of H2 (20 bar) in an autoclave for 15 h at 65 °C. Evaporation of the solvent 
gives an orange solid which is purified by flash chromatography (hexane/ethyl acetate, 4:1) 
providing product 52 as a colorless syrup (1.72 g, 99%). [ ]D20α = −20.3 (c = 0.60, CHCl3); 1H 
NMR (300 MHz, CDCl3): δ 5.05 (1H, m), 3.98 (1H, m), 3.79 (1H, m), 2.47 (1H, dd, J = 3.2, 
16.4 Hz), 2.37 (1H, dd, J = 8.9, 16.4 Hz), 2.22 (2H, bs), 1.6-1.3 (8H, m), 1.25 (6H, d, J = 6.2 
Hz), 1.18 (3H, d, J = 6.2 Hz). 13C NMR (75 MHz, CDCl3): δ 172.6, 68.1, 68.0, 68.0, 41.6, 
39.2, 36.4, 29.5, 25.6, 25.4, 23.5, 21.8; IR: 3420, 2978, 2933, 2859, 1713, 1643, 1466, 1375, 
1285, 1180, 1108, 968 cm−1. HRMS (EI): m/z calcd. 247.190933, found 247.191094. 
Compound 54. A suspension of 2-O-acetyl-2,3,6-tri-O-benzyl-α-D-glucopyranosyl trichloro 
acetimidate 53 (10.26 g, 16.1 mmol),11 diol 52 (1.65 g, 6.70 mmol), and molecular sieves 4Å 
(5 g) in CH2Cl2 (300 mL) is stirred for 30 min at ambient temperature. The solution is cooled 
to –78 °C before TMSOTf (150 µL, 0.81 mmol) is added and stirring is continued for 150 min 
at that temperature. For work-up, the mixture is filtered through a pad of Celite, the filtrate is 
quenched with sat. aq. NaHCO3, the organic layer is dried over MgSO4 and evaporated, and 
the residue is purified by flash chromatography (hexane/ethyl acetate, 6:1 → 4:1) to give 
product 54 (6.6 g, 82%). [ ]D20α = +6.3 (c = 1.01, CHCl3) 1H NMR (300 MHz, CD2Cl2): 
δ 7.40-7.15 (30H), 4.95 (1H, m), 4.87-4.75 (6H, m), 4.69-4.50 (8H, m), 4.45 (1H, d, J = 8.0 
Hz), 4.40 (1H, d, J = 8.1 Hz), 3.97 (1H, m), 3.76-3.60 (9H, m), 3.50-3.40 (2H, m), 2.77 (1H, 
dd, J = 5.6, 15.6 Hz), 2.39 (1H, dd, J = 7.4, 15 Hz), 1.96 (3H, s), 1.95 (3H, s), 1.60-1.18 
(16H, m), 0.90 (3H, d, J = 6.9 Hz). 13C NMR (75 MHz, CD2Cl2): δ 170.7, 169.4, 138.6, 
138.6, 138.4, 138.4, 128.4-127.6, 101.5, 99.5, 83.1,
 
83.1, 78.3, 78.1, 77.8, 75.5, 75.2, 75.1, 
75.1, 75.0, 74.9, 74.9, 73.5, 73.5, 73.4, 73.3, 69.1, 68.9, 67.7, 41.5, 37.1, 34.9, 29.7, 25.4, 
25.1, 21.7, 20.9, 20.8, 19.5. IR: 3031, 2932, 2863, 1749, 1728, 1605, 1497, 1454, 1373, 1232, 
1058, 736, 699 cm−1. MS (ESI): m/z 1217 ([M+Na]+). 
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Compound 55. LiAlH4 (580 mg, 15 mmol) is added in portions to a solution of compound 54 
(2.9 g, 2.42 mmol) in THF (10 mL) at 0 °C. The mixture is stirred for 1 h at that temperature 
before the cooling bath is removed. Stirring is continued until TLC shows complete 
conversion. For work-up, sat. aq. Na2SO4 is added slowly to destroy the excess of LiAlH4. 
The mixture is filtered and the remaining solid is carefully washed with ethyl acetate. The 
combined organic layers are washed with sat. aq. NH4Cl and brine, are dried over Na2SO4, 
the solvent is evaporated, and the residue is purified by flash chromatography (hexane/ethyl 
acetate, 2:1) to give product 55 as a colorless syrup (2.1 g, 82%). 24D][α = −14.2 (c = 0.40, 
CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.45-7.20 (30H, m), 4.97 (1H, d, J = 11.4 Hz), 4.96 
(1H, d, J = 11.4 Hz), 4.86 (1H, d, J = 10.9 Hz), 4.84 (3H, d, J = 11.4 Hz), 4.63-4.50 (6H, m), 
4.35 (1H, d, J = 7.7 Hz), 4.34 (1H, d, J = 7.7 Hz), 3.92-3.83 (3H, m), 3.63-3.43 (13H, m), 
3.08 (1H, t, J = 6.4 Hz), 2.55 (1H, J = 2.3 Hz, OH), 2.48 (1H, J = 2.1 Hz, OH), 1.80-1.30 
(12H, m), 1.20 (3H, d, J = 6.1 Hz). 13C NMR (100 MHz, CD2Cl2): δ 139.2, 139.0, 138.6, 
138.4, 138.1, 128.5-127.5, 102.4, 100.7, 84.7,
 
84.6, 78.0, 77.8, 76.9, 75.2, 75.0, 74.9, 74.9, 
74.9, 74.8, 74.7, 74.6, 73.5, 73.5, 69.6, 69.3, 58.4, 37.8, 37.2, 35.9, 29.9, 25.4, 25.3, 19.6. IR: 
3442, 3089, 3062, 3030, 2928, 2863, 1496, 1453, 1360, 1314, 1264, 1218, 1110, 1062, 1028, 
772, 752, 735, 698 cm−1. MS (ESI): m/z 1077 ([M+Na]+). Anal. calcd. for C64H78O13: C 
72.84, H 7.45, found C 72.91, H 7.40. 
Compound 57. Tri-n-butylphosphine (789 µL, 3.2 mmol) is added dropwise to a solution of 
triol 55 (2.03 g, 1.9 mmol) and o-nitrophenyl selenocyanate (720 mg, 3.2 mmol, 1.65 µL) in 
THF (50 mL). After the reaction is stirred for 30 min, 4 mL of aq. H2O2 (30%, w/w) are 
added and the solution is stirred for 1 h at 0 °C and then at ambient temperature until TLC 
shows complete consumption of the intermediate selenide. Sat. aq. Na2S2O3 is carefully 
added to destroy the excess H2O2 before the mixture is diluted with CH2Cl2 (50 mL) and 
stirring is continued for 15 h. The organic phase is separated, washed with sat. aq. NaHCO3, 
dried over Na2SO4, the solvent is evaporated and the residue is purified by flash 
chromatography (hexane/ethyl acetate, 10:1) to yield the desired alkene as a pale yellow oil 
(1.80 g, 90%) which shows the following spectroscopic properties: [ ]D20α = −13.6 (c = 0.35, 
CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.40-7.20 (30H, m), 5.89 (1H, ddd, J = 17.5, 10.5, 
6.9 Hz), 5.21 (1H, bd, J = 17.0 Hz), 5.10 (1H, bd, J = 10.4 Hz), 4.94 (1H, d, J = 11.4 Hz), 
4.94 (1H, d, J = 11.5 Hz), 4.84 (2H, d, J = 10.9 Hz), 4.83 (2H, d, J = 11.1 Hz), 4.64-4.50 
(6H, m), 4.33 (1H, d, J = 7.6 Hz), 4.32 (1H, d, J = 7.7 Hz), 4.09 (1H, m), 3.85 (1H, m), 3.78-
3.40 (12H, m), 2.41 (2H, bs, OH), 1.72-1.30 (10H, m), 1.18 (3H, d, J = 6.2 Hz). 13C NMR 
(100 MHz, CD2Cl2): δ 139.6, 139.2, 139.2, 138.7, 138.7, 128.4-127.6, 115.5, 102.0, 100.7, 
84.7, 81.6, 77.8, 77.8, 75.3, 75.2, 75.1, 74.9, 74.9, 74.8, 74.8, 73.5, 73.4, 69.4, 69.2, 37.2, 
34.8, 29.7, 25.4, 25.0, 19.6. IR: 3642, 3030, 2930, 2861, 1730, 1643, 1605, 1497, 1453, 1000, 
736, 698 cm−1. MS (ESI): m/z 1059 ([M+Na]+). 
NaH (16 mg, 0.67 mmol) is added to a solution of this alkene (95 mg, 0.091 mmol) and MeI 
(50 µL) in DMF (5 mL) at 0 °C. The cooling bath is removed and the mixture is stirred for 4 h 
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at 70 °C. Sat. aq. NH4Cl is added to destroy the excess NaH, the aqueous phase is extracted 
with CH2Cl2 (10 mL), the organic layer is washed with brine, dried over Na2SO4 and 
evaporated. The residue is purified by flash chromatography (hexane/ethyl acetate, 10:1) to 
give compound 57 as a colorless syrup (77 mg, 78%). [ ]D20α = −19.3 (c = 1.10, CHCl3). 1H 
NMR (400 MHz, CD2Cl2): δ 7.40-7.20 (30H, m), 5.90 (1H, ddd, J = 17.3, 10.5, 6.9 Hz), 5.21 
(1H, bd, J = 17.2 Hz), 5.10 (1H, bd, J = 10.5 Hz), 4.91 (2H, d, J = 11.2 Hz), 4.83 (2H, d, J = 
11.4 Hz), 4.79 (2H, d, J = 11.1 Hz), 4.64-4.50 (6H, m), 4.37 (1H, d, J = 7.8 Hz), 4.36 (1H, d, 
J = 7.8 Hz), 4.08 (1H, m), 3.84 (1H, m), 3.77-3.64 (4H, m), 3.60 (3H, s), 3.59 (s, 3H), 3.58-
3.50 (4H, m), 3.44-3.34 (2H, m), 3.15-3.05 (2H, m), 1.72-1.30 (10H, m), 1.20 (3H, d, J = 6.1 
Hz). 13C NMR (100 MHz, CD2Cl2): δ 139.8, 139.3, 139.3, 138.8, 138.7, 128.4-127.5, 115.2, 
102.5, 101.5, 85.0, 84.9, 84.6, 84.5, 81.6, 77.9, 77.9, 75.3, 75.2, 74.9, 74.9, 74.8, 74.8, 74.8, 
73.5, 73.4, 69.4, 69.2, 60.5, 60.3, 37.4, 34.9, 29.9, 25.4, 25.0, 19.4. IR: 3030, 2930, 2860, 
1496, 1453, 1076, 735, 697 cm−1. MS (ESI): m/z 1087 ([M+Na]+). Anal. calcd. for 
C66H80O12: C 74.41, H 7.57, found C 74.52, H 7.56. 
Aldehyde 58. O3 is bubbled through a solution of alkene 57 (220 mg, 0.21 mmol) in CH2Cl2 
(30 mL) at –78 °C. After the solution turned blue, the mixture is purged with argon for 5 min. 
Me2S (250 µL, 3.4 mmol, 16 eq.) is then added and the mixture is stirred for 60 min at −78 
°C. After warming to room temperature, all volatiles are evaporated and the residue is quickly 
passed through a short column of silica gel (hexane/ethyl acetate, 5:1) to yield aldehyde 58 as 
a colorless syrup (210 mg, 95%). [ ]D20α = +5.8 (c = 0.80, CHCl3). 1H NMR (400 MHz, 
CD2Cl2): δ 9.66 (1H, d, J = 2.8 Hz), 7.5-7.10 (30H, m), 4.95-4.45 (12H, m), 4.37 (1H, d, J = 
7.2 Hz), 4.36 (1H, d, J = 7.6 Hz), 3.89-3.37 (18H, m), 3.22 (1H, t, J = 8.7 Hz), 3.08 (1H, m), 
1.75-1.30 (10H, m), 1.20 (3H, d, J = 6.2 Hz). 13C NMR (100 MHz, CD2Cl2): δ 203.4, 139.3, 
139.1, 138.8, 138.7, 138.6, 138.5, 128.4-127.5, 104.4, 101.5, 85.2, 84.9, 84.6, 84.5, 84.3, 
77.9, 77.5, 75.4, 75.2, 75.0, 74.9, 74.8, 73.5, 69.4, 68.9, 60.5, 60.3, 37.3, 30.5, 29.6, 25.2, 
24.8, 19.4. IR: 3030, 2930, 2860, 1731, 1605, 1496, 1453, 1075, 751, 698 cm−1. MS (ESI): 
m/z 1089 ([M+Na]+). 
Compound 59. A solution of PPh3 (49 mg, 0.187 mmol, 1.5 eq.) and 1-phenyl-5-mercapto 
tetrazole (34 mg, 0.187 mmol, 1.5 eq.) in THF (3 mL) is stirred at 0°C for 5 min before a 
solution of alcohol 12 (105 mg, 0.126 mmol) in THF (2 mL) is added. Diisopropyl 
azodicarboxylate (DIAD, 37 µg, 0.187 mmol, 1.5 eq.) is added dropwise to the resulting 
mixture which is allowed to stir for 4 h. For work-up, the solvent is evaporated and the 
residue is purified by flash chromatography (hexane/ethyl acetate, 6:1) to yield sulfide 59 as a 
syrup (101 mg, 85%). [ ]D20α = +6.3° (c = 1.00, CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.61-
7.56 (5H, m), 7.38-7.22 (15H, m), 4.96 (2H, t, J = 11.5 Hz), 4.86 (1H, d, J = 11.0 Hz), 4.81 
(1H, d, J = 11 Hz), 4.73 (1H, d, J = 11.1 Hz), 4.58 (1H, d, J = 11 Hz), 4.54 (1H, d, J = 7.8 
Hz), 4.30 (1H, dd, J = 12.8, 1.8 Hz), 4.24 (1H, dd, J = 12.8, 4.6 Hz), 4.07 (1H, m), 3.67 (1H, 
t, J = 8.9 Hz), 3.55-3.48 (2H, m), 3.40 (2H, t, J = 7.3 Hz), 3.38 (1H, t, J = 8.0 Hz), 2.72 (1H, 
dd, J = 5.5, 15.0 Hz), 2.42 (1H, dd, J = 7.7, 15.0 Hz), 2.05 (3H, s), 1.83 (2H, m), 1.6 (2H, m), 
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1.46 (9H, s), 1.40-1.20 (22H). 13C NMR (100 MHz, CD2Cl2): δ 170.6, 170.5, 138.9, 138.8, 
138.3, 130.2, 129.9, 128.4-127.6, 124.0, 103.0, 84.8, 82.3, 80.2, 77.8, 77.2, 75.6, 74.9, 74.7, 
72.9, 63.2, 42.2, 34.6, 33.5, 29.8-28.7, 28.0, 25.1, 20.7. IR: 2925, 2853, 1742, 1727, 1597, 
1499, 1454, 1366, 1454, 1236, 1153, 1085, 757, 698 cm-1. MS (ESI): m/z 1015 ([M+Na]+). 
Anal. calcd. for C57H76N4O9S: C 68.92, H 7.71, N 5.64, found C 69.02, H 7.66, N 5.52. 
Compound 60. To a stirred solution of sulfide 59 (280 mg, 0.281 mmol) in EtOH (6 mL) at rt 
is added dropwise a yellow solution of ammonium molybdate tetrahydrate (38 mg, 0.031 
mmol) in aqueous hydrogen peroxide (0.36 mL, 30 wt%, 3.1 mmol)). The resulting mixture is 
vigorously stirred for 20 h and then partitioned between CH2Cl2 and aq. Na2S2O3. The 
organic phase is dried with Na2SO4 and the solvent removed in vacuo. Purification by flash 
chromatography (hexane – ethyl acetate, 6:1) yields sulfone 60 as a colorless oil (280 mg, 
97%). [ ]D20α = +7.0° (c = 1.00, CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.75-7.60 (5H, m), 
7.40-7.35 (15H, m), 4.98 (2H, t, J = 12.1 Hz), 4.88 (1H, d, J = 11.0 Hz), 4.83 (1H, d, J = 11 
Hz), 4.76 (1H, d, J = 11.2 Hz), 4.60 (1H, d, J = 10.9 Hz), 4.56 (1H, d, J = 7.8 Hz), 4.32 (1H, 
bd, J = 11 Hz), 4.26 (1H, dd, J = 12, 3.3 Hz), 4.08 (1H, m), 3.75-3.65 (3H, m), 3.55-3.50 (2H, 
bs), 3.41 (1H, dd, J = 7.8, 9.1 Hz), 2.74 (1H, dd, J = 5.6, 15 Hz), 2.44 (1H, dd, J = 7.7, 15 
Hz), 2.06 (3H, s), 1.94 (2H, m), 1.63 (2H, m), 1.47 (9H, s), 1.40-1.20 (22H). 13C NMR (400 
MHz, CD2Cl2): δ 170.6, 170.5, 138.9, 138.8, 138.3, 131.5, 129.7, 128.4-127.6, 
103.1, 84.8, 82.3, 80.2, 77.8, 77.2, 75.6, 74.9, 74.7, 72.9, 63.2, 56.2, 42.2, 34.6, 29.8-29.0, 
29.6, 28.0, 25.1, 20.7. IR: 2925, 2854, 1742, 1728, 1596, 1498, 1454, 1366, 1233, 1152, 1069, 
760, 698 cm-1. MS (ESI): m/z 1047 ([M+Na]+). Anal. calcd. for C57H76N4O11S: C 66.77, H 
7.47, N 5.46, found C 66.88, H 7.56, N 5.30. 
Compound 62. A solution of PPh3 (110 mg, 0.420 mmol) and 1-phenyl-5-mercapto tetrazole 
(75 mg, 0.420 mmol) in THF (10 mL) is stirred at 0 °C for 5 min before a solution of alcohol 
17 (470 mg, 0.281 mmol) in THF (6 mL) is added. Diisopropyl azodicarboxylate (DIAD, 84 
µg, 0.420 mmol) is then added dropwise and the mixture is stirred for 4 h at ambient 
temperature. For work-up, the solvent is evaporated and the residue is purified by flash 
chromatography (hexane/ethyl acetate, 6:1) to yield sulfide 62 as a colorless oil (467 mg, 
91%). 24D][α = +22.8 (c = 1.00, CHCl3). 1H NMR (400 MHz, CD2Cl2): δ 7.70-7.20 (45H), 
5.00 (2H, d, J = 11 Hz), 4.95 (2H, d, J = 11.0 Hz), 4.86 (2H, d, J = 11.2 Hz), 4.82 (2H, d, J = 
11.0 Hz), 4.77 (2H, d, J = 11.2 Hz), 4.58 (2H, d, J = 11.1 Hz), 4.47 (2H, d, J = 7.8 Hz), 4.33 
(2H, d, J = 10.8), 4.10-4.00 (4H, m), 3.71 (2H, t, J = 6.7 Hz), 3.67 (2H, t, J = 8.9 Hz), 3.58-
3.50 (4H, m), 3.45 (2H, dd, J = 7.9, 9.0 Hz), 3.41 (2H, t, J = 7.4 Hz), 2.92 (2H, dd, J = 6.0, 
16.0 Hz), 2.39 (2H, dd, J = 5.9, 16.0 Hz), 1.84 (2H, m), 1.65-1.10 (50H, m), 1.08 (9H, s). 13C 
NMR (100 MHz, CD2Cl2): δ 171.4, 138.9, 138.8, 138.3, 135.6, 134.4, 130.2-124.4, 105.3, 
84.8, 82.3, 79.3, 77.8, 75.6, 74.9, 74.8, 72.4, 64.2, 63.6, 41.6, 36.2, 33.5, 32.7, 29.9-29.5, 
26.8, 25.9, 25.4, 19.2. IR: 2926, 2854, 1735, 1109, 1070 cm-1. Anal. calcd. for 
C111H142N4O15SSi: C 72.75, H 7.81, found C 72.63, H 7.65. 
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Compound 63. To a stirred solution of sulfide 62 (110 mg, 0.281 mmol) in EtOH/CH2Cl2 
(3/2 v/v, 2.5 mL) is added dropwise a yellow solution of ammonium molybdate tetrahydrate 
(8 mg, 0.007 mmol) in aqueous hydrogen peroxide (30 wt%, 80 µL, 0.68 mmol). The 
resulting mixture is vigorously stirred for 20 h and is then partitioned between CH2Cl2 and 
aq. Na2S2O3. The organic phase is dried over Na2SO4, the solvent is evaporated and the 
residue is purified by flash chromatography (hexane/ethyl acetate, 6:1) to give sulfone 63 as a 
colorless oil (75 mg, 67%). [ ]D20α = +23.2 (c = 0.80, CHCl3). 1H NMR (300 MHz, CD2Cl2): δ 
7.70-7.20 (45H), 4.97 (2H, d, J = 11.6 Hz), 4.93 (2H, d, J = 12.0 Hz), 4.83 (2H, d, J = 12.0 
Hz), 4.79 (2H, d, J = 11.3 Hz), 4.74 (2H, d, J = 11.2 Hz), 4.55 (2H, d, J = 11.1 Hz), 4.48 
(2H, d, J = 7.8 Hz), 4.30 (2H, d, J = 11.6), 4.10-4.00 (4H, m), 3.73-3.60 (6H, m), 3.58-3.50 
(4H, m), 3.42 (2H, bt, J = 8.2 Hz), 2.89 (2H, dd, J = 6.0, 16.0 Hz), 2.35 (2H, dd, J = 5.6, 16.0 
Hz), 1.92 (2H, m), 1.65-1.10 (50H, m), 1.05 (9H, s). 13C NMR (75 MHz, CD2Cl2): δ 171.5, 
138.8, 138.7, 138.3, 135.6, 134.4, 131.6, 130.2-125.4, 105.3, 84.8, 82.3, 79.3, 77.7, 75.6, 
74.9, 74.8, 72.3, 64.1, 63.6, 56.1, 41.6, 36.2, 32.7, 29.9-29.0, 26.7, 25.9, 25.4, 19.2; MS (ESI): 
m/z 1885 ([M+Na]+). Anal. calcd. for C111H142N4O17SSi: C 71.51, H 7.68, found C 71.40, 
H 7.60. 
Compound 65. LiHMDS (6.5 mg, 0.039 mmol) is added to a stirred solution of sulfone 63 
(42 mg, 0.023 mmol) in freshly distilled DME (2 mL) at –78 °C and the resulting yellow 
solution is stirred for 10 minutes. A solution of aldehyde 58 (36 mg, 0.034 mmol, 1.5 eq.) in 
DME (1 mL) is then introduced and the mixture is stirred for 60 min at –78 °C before the 
cooling bath is removed and the reaction is quenched after another 30 min by adding sat. aq. 
NH4Cl and CH2Cl2. The organic layer is dried over Na2SO4, the solvent is evaporated and 
the residue is purified by flash chromatography (hexane/ethyl acetate, 5:1) to give alkene 64 
as a colorless syrup (37 mg, 61%, E/Z ~ 1:1). 
Palladium on charcoal (10% w/w, 70 mg) is added to a solution of this compound (120 mg, 
0.017 mmol) in ethyl acetate (10 mL) and the resulting mixture is stirred under H2 (1 atm) for 
6 h. The catalyst is then filtered off and is very carefully rinsed with ethyl acetate/hexane (1/1, 
500 mL). The combined filtrates are evaporated to give product 65 as a colorless syrup (85 
mg, 72%). [ ]D20α = +12.2 (c = 0.80, CHCl3); 1H NMR (400 MHz, CD2Cl2): δ 7.70-7.65 (4H, 
m), 7.45-7.20 (66H, m), 5.01-4.72 (16H, m), 4.64-4.52 (8H, m), 4.49 (2H, d, J = 7.8 Hz), 4.37 
(1H, d, J = 7.8 Hz), 4.34 (1H, d, J = 7.7 Hz), 4.32 (2H, bd, J = 10.2), 4.10-4.00 (4H, m), 3.84 
(1H, m), 3.77-3.48 (17H, m), 3.59 (6H, s), 3.43 (2H, bt, J = 9 Hz), 3.40 (2H, m), 3.10-3.04 
(2H, m), 2.91 (2H, dd, J = 6.0, 16.0 Hz), 2.37 (2H, dd, J = 5.8, 16.0 Hz), 1.70-1.15 (69H, m), 
1.06 (9H, s). 13C NMR (100 MHz, CD2Cl2): δ 171.4, 139.3, 138.9, 138.8, 138.7, 138.3, 
135.7, 134.4, 129.6, 130.2-125.4, 105.3, 102.8, 101.5, 85.1, 84.9, 84.8, 84.7, 84.5, 82.3, 80.1, 
79.3, 78.0, 77.8, 75.6, 75.3, 75.2, 75.0, 74.9, 74.9, 74.8, 73.6, 73.5, 72.4, 69.4, 64.2, 63.6, 
60.5, 60.3, 41.6, 37.5, 36.2, 35.1, 34.2, 32.7, 29.9-29.0, 26.8, 25.9, 25.5 25.1, 19.4, 19.2. 
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Compound 66. A solution of compound 65 (75 mg, 0.028 mmol) and tetra-n-
butylammonium fluoride trihydrate (28 µL of 1M solution in THF, 0.028 mmol) in THF (2 
mL) is stirred at ambient temperature until TLC shows complete conversion (ca. 2 h). 
Evaporation of the solvent gives a viscous oil which is purified by flash chromatography 
(hexane/ethyl acetete, 2:1) to yield alcohol 66 as a colorless oil (65 mg, 95%); [ ]D20α  = +15.1 
(c = 0.50, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.31-7.20 (60H, m), 4.96-4.52 (24 H, 
12AB), 4.47 (2H, d, J = 7.8 Hz), 4.34 (2H, dd, J = 1.6, 11.6 Hz), 4.33 (1H, d, J = 7.7 Hz), 
4.29 (1H, d, J = 7.8 Hz), 3.98 (4H, m), 3.82 (1H, m), 3.73-3.65 (4H, m), 3.64 (2H, vt), 3.61 
(2H, t, J = 6.6 Hz), 3.60 (1H, m), 3.59 (3H, s), 3.57 (3H, s), 3.55-3.45 (6H, m), 3.45 (2H, vt), 
3.40 (2+2H, m+t), 3.11 (2H, m), 2.93 (2H, dd, J = 5.1, 15.9 Hz), 2.38 (2H, dd, J = 7.1, 15.9 
Hz), 1.70-1.15 (66H, m), 1.18 (3H, d, J = 7.7 Hz). 13C NMR (100 MHz, CDCl3): δ 171.3, 
138.8-137.7 and 128.4-127.4, 104.9, 102.8, 101.5, 85.2, 85.0, 84.7, 84.4, 84.3, 82.3, 80.3, 
78.6, 77.8, 77.7, 75.6, 75.4, 75.1, 75.0-74.8, 73.5, 73.4, 72.2, 69.2, 63.5, 63.0, 60.6, 60.5, 
41.4, 37.3, 35.9, 34.9, 34.1, 32.8, 30.0-29.4, 25.7, 25.3, 25.0, 19.5. Anal. calcd. for 
C153H198O27: C 74.42, H 8.08, found C 74.30, H 8.20. 
Compound 67. A mixture of PCC (11 mg, 0.05 mmol) and alcohol 66 (60 mg, 0.024 mmol) 
is stirred in dichloromethane (3 mL) for 1.5 h (TLC) before it is poured onto a short column 
of silica gel. Elution with hexane/ethyl acetate (4:1) gives aldehyde 67 (50 mg, 83%) which is 
directly used in the next step without further characterization. 
Compound 68. A flame-dried flask is charged with trans-(1S,2S)-bis(trifluoromethyl-
sulfonylamido)-cyclohexane 39 (4 mg, 0.01 mmol), toluene (1mL) and Ti(OiPr)4 (26 µL, 
0.10 mmol) and the mixture is stirred at 40 °C for 30 min under argon. After being cooled to 
−50 °C, the zinc reagent 38 (0.10 mmol, 5 eq.) is added followed by a solution of aldehyde 67 
(50 mg, 0.02 mmol) in toluene (2 mL). The resulting mixture is slowly (1 h) warmed to –20 
°C before it is quenched with aq. sat. NH4Cl and diluted with tert-butyl methyl ether. The 
organic phase is successively washed with HCl (1M), water and brine, is dried (Na2SO4) and 
evaporated, and the residue is purified by flash chromatography (hexane/ethyl acetate, 3:1) to 
give alcohol 68 as a colorless oil (40 mg, 81% over both steps). [ ]D20α = +9.5 (c = 1.50, 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.31-7.24 (65H, m), 4.96-4.43 (26H, 13AB), 4.47 
(2H, d, J = 7.8 Hz), 4.34 (2H, dd, J = 1.6, 11.6 Hz), 4.33 (1H, d, J = 7.7 Hz), 4.29 (1H, d, J = 
7.8 Hz), 3.98 (4H, m), 3.83 (1H, m), 3.73-3.66 (4H, m), 3.64 (2H, vt), 3.60 (2H, m), 3.59 (3H, 
s), 3.58 (3H, s), 3.54-3.47 (6H, m), 3.44 (2H, vt), 3.40 (2H, m), 3.40 (2H, dd, J = 7.9, 9.1 Hz), 
3.11 (2H, m), 2.93 (2H, dd, J = 5.1, 15.8 Hz), 2.38 (2H, dd, J = 7.0, 15.9 Hz), 1.62-1.12 
(76H, m), 1.18 (6H, d, J = 6.1 Hz). 13C NMR (100 MHz, CDCl3): δ 171.3, 138.9-137.8, 
128.5-127.3, 104.9, 102.8, 101.5, 85.2, 85.0, 84.7, 84.5, 84.3, 82.3, 80.3, 78.7, 77.9, 77.8, 
75.7, 75.5, 75.1, 74.9-74.8, 73.5, 73.4, 72.2, 72.0, 70.2, 69.3, 63.5, 60.6, 60.5, 41.4, 37.5, 
37.4, 37.3, 36.6, 35.9, 34.9, 34.1, 30.0-29.5, 25.7, 25.6, 25.3, 25.0, 19.6, 19.5. Anal. calcd. for 
C167H218O28: C 75.03, H 8.22, found C 75.20, H 8.12. 
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Compound 69. TMSOTf (5 µL) is added to a solution of alcohol 68 (35 mg, 0.013 mmol) 
and trichloroacetimidate 41 (12 mg, 0.02 mmol) in CH2Cl2 (2 mL) and CH3CN (2 mL) at –50 
°C and stirring is continued for 30 min at −50 → –40 °C. After neutralization with 
triethylamine and evaporation of the solvent, the residue is purified by flash chromatography 
(hexane-ethyl acetate, 4:1) to give product 69 as a viscous oil (35 mg, 87%). [ ]D20α = +6.1 (c = 
1.50, CHCl3). 1H NMR (600 MHz, CDCl3): δ 7.31-7.24 (65H, m), 4.95-4.44 (32H, 16AB), 
4.47 (2H, d, J = 7.4 Hz), 4.33 (3H, bd, J = 8 Hz), 4.31 (1H, d, J = 7.8 Hz), 4.29 (1H, d, J = 
7.7 Hz), 3.98 (4H, m), 3.83 (1H, m), 3.73-3.65 (6H, m), 3.64 (2H, vt), 3.62 (2H, m), 3.59 (3H, 
s), 3.59 (3H, s), 3.58 (3H, s), 3.56-3.48 (9H, s), 3.45 (2H, vt), 3.42 (3H, m), 3.40 (2H, vt), 
3.12 (3H, vt), 2.93 (2H, dd, J = 5.2, 15.9 Hz), 2.38 (2H, dd, J = 6.9, 15.9 Hz), 1.65-1.14 
(76H, m), 1.18 (6H, d, J = 6.1 Hz). 13C NMR (150 MHz, CDCl3): δ 171.3, 139.1-137.7, 
128.3-127.5, 104.9, 102.77, 102.76, 101.5, 85.2, 85.0, 84.7, 84.43, 84.42, 84.3, 82.3, 80.3, 
78.8, 77.83, 77.82, 77.7, 75.7, 75.5, 75.4, 75.1, 74.9-74.9, 73.5, 73.4, 72.2, 70.2, 69.3, 69.2, 
63.5, 60.60, 60.59, 60.5, 41.4, 37.2, 36.6, 35.9, 34.9, 34.1, 33.9, 30.0-29.5, 25.5, 25.4, 25.3, 
25.3, 25.0, 25.0, 19.6, 19.5. Anal. calcd. for C195H248O33: C 75.07, H 8.01, found C 75.22, H 
8.10. 
Cycloviracin B1 (1). Palladium on charcoal (10% w/w, 10 mg) is added to a solution of 
compound 69 (25 mg, 0.008 mmol) in EtOAc (1 mL) and EtOH (2 mL) and the resulting 
mixture is stirred under H2 (1 atm) overnight. The suspension is filtered through a plug of 
Celite and the filtrate is evaporated to give analytically pure cycloviracin 1 as an amorphous 
solid (12 mg, 89%). [ ]D20α = −14.1 (c = 0.70, MeOH); [lit. 26D][α = −15.6 (c = 0.5, MeOH)]; 1H 
NMR (600 MHz, pyridine-d5): δ 5.23 (3H, bd, J = 9.7 Hz), 4.89 (2H, d, J = 7.7 Hz), 4.85 and 
4.84 (2H, 2d, J = 7.7 and 7.8 Hz), 4.81 (1H, d, J = 7.8 Hz), 4.56 (2H, dd, J = 8.4, 11.5 Hz), 
4.50 (3H, bd, J = 14.9 Hz), 4.46 (2H, m), 3.37-4.32 (3H, m), 4.19-4.11 (10H, m), 4.05-3.92 
(8H, m), 3.88-3.83 (3H, m), 3.816 (3H, s), 3.815 (3H, s), 3.77 (3H, s), 3.62 (2H, dd, J = 4.5, 
15.8 Hz), 3.44-3.39 (3H, m), 2.79 (2H, dd, J = 9.1, 15.3 Hz), 1.80-1.20 (76H, m), 1.33 (2H, d, 
J = 6.1 Hz), 1.22 (3H, d, J = 6.1 Hz). 13C NMR (150 MHz, pyridine-d5): δ 171.73, 106.48, 
103.19, 103.15, 101.84, 85.37, 85.15, 79.34, 79.33, 78.96, 78.35, 78.15, 78.02, 77.79, 77.68, 
75.18, 74.62, 74.21, 72.15, 71.92, 71.82, 67.04, 65.42, 62.96, 62.88, 60.83, 60.81, 60.67, 
42.49, 40.22, 37.82, 36.07, 35.42, 35.40, 34.26, 30.49, 30.42, 30.25, 30.24, 30.07-29.96, 
26.48, 25.75, 25.71, 25.63, 25.64, 25.34, 25.25, 24.36, 19.56. These data are in excellent 
agreement with those of authentic cycloviracin B1, cf. Table 2 in the Text. For copies of the 
1H and 13C NMR spectra see the Supporting Information of our Communication published in 
J. Am. Chem. Soc. 2002, 124, 10274. 
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Scheme S-1. Preparation of the Building Block 24 Required for the Synthesis of the (3R,3’S)-
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14-Brom-1-tetradecene (S-2). To a vigorously stirred solution of 1,13-tetradecene S-1 (15 g, 
77.3 mmol) and dibenzoylperoxide (100 mg) in hexane (200 mL) is slowly added a solution 
of HBr (6.1 g, 75 mmol) in ethyl ether at 0 °C. The mixture is warmed to ambient temperature 
and stirring is continued for 1 h. The reaction mixture is diluted with MTBE and carefully 
washed with aq. sat. NaHCO3, water and brine. Evaporation of the solvents gives a syrup 
which is purified by distillation. After a fore-run (2-3 × 10-2 mbar, 55-81 °C) containing 
unreacted starting material (ca. 6.5 g), the desired monobromide S-2 is collected (2-3 × 10-2 
mbar, 97-110 °C) (8.5 g, 40%). 1H NMR (300 MHz, CDCl3): δ 5.85-5.74 (m, 1H), 5.02-4.90 
(m, 2H), 3.40 (t, 2H, J = 6.9 Hz), 2.07-2.00 (m, 2H), 1.90-1.80 (m, 2H), 1.60-1.25 (m, 16 H). 
13C NMR (75 MHz, CDCl3): δ 139.2, 114.1, 34.0, 33.8, 32.9, 32.6, 29.6, 29.5-27.8, 26.5. 
HRMS (EI): m/z calcd. for C14H27Br 274.12963, found 274.12968. 
(S)-2-[2-(4-methoxy-benzyloxy)-ethyl]-oxirane (S-3): To a solution of 3-buten-1-ol (10.0 g, 
138.67 mmol) in dry DMF (200 mL) is added sodium hydride (6.6 g, 278 mmol) at 0 °C 
under Ar. After stirring for 10 min, p-methoxybenzyl chloride (18.9 mL, 140 mmol) is 
introduced and the mixture is stirred at ambient temperature until TLC shows complete 
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conversion of the substrate. For work-up, a few drops of methanol are added to destroy excess 
sodium hydride before the mixture is diluted with MTBE and washed with water and brine. 
The organic layer is dried and the solvent is evaporated under reduced pressure. The crude 
product is redissolved in CH2Cl2 and m-chloroperbenzoic acid (48 g, 2 eq.) is added to the 
mixture which is allowed to stir overnight. Aq. sat. Na2S2O3 is then added, the mixture is 
diluted with CH2Cl2 and is consecutively washed with aq. sat. Na2S2O3 and brine. The 
organic phase is dried and concentrated to afford a orange-red syrup containing racemic 
epoxide (26.6 g, 92%) which was resolved as follows: 
A 25 mL flask is charged with (1S,2S)-1,2-cyclohexanediamino-N,N’-bis(3,5-di-t-butyl-
salicylidene)cobalt(II) (345 mg, 0.57 mmol),12 the crude racemic epoxide S-3 prepared above 
(5.5 g, 28.6 mmol), and acetic acid (32 µL, 0.57 mmol) and the resulting mixture is stirred for 
1 h at ambient temperature. The mixture is then cooled to 0 °C before THF (5 mL) and water 
(280 µL, 15.73 mmol) are introduced. The reaction is stirred at ambient temperature for 48 h. 
Evaporation of the solvent under reduced pressure and Kugelrohr-distillation of the residue 
(2-3 × 10-2 mbar, 130-150 °C) affords pure S-epoxide S-3 as a yellow oil: [ ]D20α = −10.6 (c = 
1.00, CHCl3). 1H NMR (300 MHz, CHCl3): δ 7.24 (d, 2H, J = 8.9 Hz), 6.87 (d, 2H, J = 8.9 
Hz), 4.45 (s, 2H), 3.80 (s, 3H), 3.56-3.63 (m, 2H), 3.06 (m, 1H), 2.77 (dd, 1H, J = 4.0, 5.1 
Hz), 2.51 (dd, 1H, J = 2.7, 5.1 Hz), 1.93-1.73 (m, 2H). 13C NMR (75 MHz, CDCl3): δ 159.2, 
130.4, 129.2, 114.2, 72.7, 66.7, 55.9, 50.1, 47.1, 32.9. IR: 3483, 3045, 2860, 1613, 1514, 823 
cm –1. HRMS (EI): m/z calcd. for C12H16O3: 208.1099, found 208.1098. 
(R)-1-O-para-Methoxybenzyl-octadec-17-ene-1,3-diol (S-4). Magnesium (365 mg, 15 
mmol) is activated overnight with a few crystals of iodine under Ar before it is suspended in 
THF (10 mL). A solution of bromide S-2 (4.10 g, 15 mmol) in THF (5 mL) is slowly added to 
this suspension at 70 °C and the resulting mixture is refluxed for 2 h. The Grignard reagent 
thus obtained is cooled to –40 °C and diluted with THF (50 mL). CuCl(COD) (1 mmol) is 
introduced before a solution of epoxide S-3 (2.0 g, 9.6 mmol) in THF (5 mL) is added 
dropwise and the resulting mixture is stirred for 3 h while the temperature is allowed to rise to 
–10 °C. The reaction is quenched with sat. aq. NH4Cl, is diluted with MTBE and successively 
washed with aq. NH4Cl and brine. The organic phase is dried and concentrated, and the 
residue is purified by flash chromatography (hexane/ethyl acetate, 4:1) to give alcohol S-4 
(2.5 g, 64%) as a colorless solid: mp 37-38 °C. [ ]D20α = +6.6 (c = 1.00, CHCl3). 1H NMR (300 
MHz, CHCl3): δ 7.25 (d, 2H, J = 8.9 Hz), 6.85 (d, 2H, J = 8.7 Hz), 5.90-5.70 (m, 1H), 5.05-
4.90 (m, 2H), 4.45 (s, 3H), 3.70-3.55 (m, 4H), 2.10-2.00 (m, 2H), 1.75-1.65 (m, 2H), 1.50-
1.20 (m, 24H). 13C NMR (75 MHz, CDCl3): δ 159.2, 139.2, 130.0, 129.3, 114.0, 113.8, 72.9, 
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71.5, 69.0, 55.2, 37.4, 36.3, 33.7, 29.7-28.9, 25.6. IR: 3340, 2917, 2849, 1614, 1515, 1251, 
818 cm –1. HRMS (EI): m/z calcd. for C26H44O3: 404.3290, found 404.3288. 
(3R)-1-O-para-Methoxybenzyl-3-(2,3,4,6-tetra-O-pivaloyl-β-D-glucopyranosyl)-octadec-
17-ene-1,3-diol (S-6): A solution of 2,3,4,6-tetra-O-pivaloyl-α-D-glucopyranosyl bromide S-5 
(4.0 g, 6.0 mmol)13 in CH2Cl2 (20 mL) is added to a mixture of alcohol S-4 (2.2 g, 5.44 
mmol), silver triflate (2.8 g, 11.0 mmol) and 2,6-di-tert-butylpyridine (5.0 mL, 22.0 mmol) in 
CH2Cl2 (80 mL) at –40 °C under Ar. The reaction is stirred at this temperature for 0.5 h and 
then at −20 °C for an additional hour. For work-up, the mixture is diluted with CH2Cl2 before 
it is filtered through a pad of Celite. Evaporation of the filtrate gives a syrup which is purified 
by flash chromatography (hexane/ethyl acetate, 4:1) to give glycoside S-6 (4.3 g, 88%) as a 
colorless oil. [ ]D20α = −11.5 (c = 0.95, CHCl3). 1H NMR (300 MHz, CHCl3): δ 7.25 (d, 2H, J 
= 8.9 Hz), 6.85 (d, 2H, J = 8.7 Hz), 5.88-5.75 (m, 1H), 5.30 (t, 1H, J = 9.4 Hz), 5.11 (t, 1H, J 
= 9.9 Hz), 5.03-4.72 (m, 2H), 4.28 (d, 1H, J = 7.9 Hz), 4.44-4.34 (AB, 2H), 4.19 (dd, 1H, J = 
1.7, 12.3 Hz), 4.02 (dd, 1H, J = 5.3, 12.2 Hz), 3.80 (s, 3H), 3.80-3.74 (m, 1H), 3.66 (ddd, 1H, 
J = 1.7, 5.2, 10.1 Hz), 3.53 (t, 1H, J = 6.7 Hz), 2.07-2.00 (m, 2H), 1.80-1.73 (m, 2H), 1.50-
1.20 (m, 24H), 1.20, 1.15, 1.14, 1.11 (4s, 12H). 13C NMR (75 MHz, CDCl3): δ 178.0, 177.2, 
176.4, 176.3, 159.1, 139.2, 130.8, 129.1, 114.0, 113.7, 99.4, 76.4, 72.7, 72.6, 72.0, 71.5, 68.1, 
66.9, 61.9, 55.2, 38.8, 38.7, 38.7, 34.8, 34.5, 33.8, 29.8, 29.6-29.5, 29.1, 28.9, 27.1-27.0, 25.2; 
IR: 2971, 2927, 2854, 1745, 1613, 1480, 1141 cm–1. HRMS (ESI): m/z calcd. for 
(C52H86O12+Na): 925.6017; found 925.6013 ([M+Na]+). 
(3R)-1-O-para-Methoxybenzyl-3-[6-O-(tert-butyldimethylsilyl)-β-D-glucopyranosyl]-
octadec-17-ene-1,3-diol (S-7). A solution of glycoside S-6 (4.30 g, 4.76 mmol) in MeOH (50 
mL) is reacted overnight with NaOMe (1.54 g, 28.56 mmol) before it is diluted with ethyl 
acetate and successively washed with water (3 times) and brine. The organic layer is dried and 
evaporated. To a solution of the residue in CH2Cl2 (50 mL) and triethylamine (0.84 mL, 6 
mmol) are added tert-butyldimethylsilyl chloride (755 mg, 5 mmol) and 4-
dimethylaminopyridine (10 mg) and the resulting mixture is stirred overnight. Evaporation of 
all volatiles followed by flash chromatography of the crude material on silica gel 
(hexane/ethyl acetate, 1:1) gives compound S-7 as a colorless oil (2.0 g, 62%). [ ]D20α = −29.9 
(c = 1.17, CHCl3); 1H NMR (300 MHz, CHCl3): δ 7.25 (d, 2H, J = 8.9 Hz), 6.86 (d, 2H, J = 
8.7 Hz), 5.90-5.75 (m, 1H), 5.05-4.90 (m, 2H), 4.41 (AB, 2H), 4.31 (d, 1H, J = 7.7 Hz), 3.90 
(dd, 1H, J = 5.0, 10.5 Hz), 3.80-3.70 (m, 2H), 3.80 (s, 3H), 3.60-3.50 (m, 4H), 3.38-3.30 (m, 
2H), 2.08-2.00 (m, 2H), 1.85-1.75 (m, 2H), 1.60-1.20 (m, 26H), 0.88 (s, 3H), 0.07, 0.06 (2s, 
3H). 13C NMR (75 MHz, CDCl3): δ 159.1, 139.2, 130.7, 129.1, 114.1, 113.7, 101.2, 76.2, 
73.9, 73.6, 73.2, 72.6, 66.9, 64.8, 55.3, 34.9, 23.4, 33.8, 29.8-28.9, 25.8, 25.2, 18.2, -5.5. IR: 
3430, 2925, 2835, 1514, 1247, 1033 cm-1. Anal. calcd. for C38H68O8Si: C 67.02, H 10.06, 
found C 67.00, H 9.98.  
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(3R)-1-O-para-Methoxybenzyl-3-[2,3,4-tri-O-benzyl-6-O-(tert-butyldimethylsilyl)-β-D-
glucopyranosyl]-octadec-17-ene-1,3-diol (S-8). To a stirred solution of compound S-7 (1.8 
g, 2.64 mmol) in dry DMF (50 mL) are added NaH (760 mg, 31.6 mmol) and benzyl bromide 
(2.5 mL, 21 mmol) at 0 °C. The reaction mixture is stirred at ambient temperature for 3 h 
before residual NaH is destroyed with a few drops of methanol. The reaction mixture is 
diluted with MTBE, washed with water and brine, the organic phase is dried and evaporated. 
Purification of the residue by flash chromatography (hexane/ethyl acetate, 15:1) provides 
product S-8 (2.3 g, 92%) as a colorless oil. [ ]D20α = −1.9 (c = 1.13, CHCl3). 1H NMR (300 
MHz, CHCl3): δ 7.30-7.24 (m, 17 H), 6.86 (d, 2H, J = 8.7 Hz), 5.90-5.70 (m, 1H), 4.96-4.77 
(m, 8H), 4.42 (m, 3H), 3.85-3.77 (m, 3H), 3.83 (s, 3H), 3.65-3.55 (m, 4H), 3.36-3.32 (m, 1H), 
3.25-3.20 (m, 1H), 2.10-1.88 (m, 2H), 1.95-1.80 (m, 2H), 1.62-1.10 (m, 26H), 0.89 (s, 3H), 
0.07, 0.05 (2s, 3H). 13C NMR (75 MHz, CDCl3): δ 159.1, 129.3, 138.7, 138.6, 129.1-127.5, 
114.1, 113.7, 102.1, 84.9, 82.6, 77.6, 76.6, 75.8, 75.7, 75.0, 74.9, 72.5, 67.5, 55.2, 34.3, 33.8, 
29.9-29.0, 25.9, 25.1, 18.3, -4.9, -5.3. IR: 2926, 2854, 1513, 1094, 1071 cm-1. MS (ESI): m/z 
973 ([M+Na]+). Anal. calcd. for C59H86O8Si: C 74.48, H 9.11, found C 74.40, H 8.98;  
(3R)-3-[2,3,4-Tri-O-benzyl-6-O-(tert-butyldimethylsilyl)-β-D-glucopyranosyl]-octadec-17-
ene-1,3-diol (S-9). To a stirred solution of compound S-8 (2.3 g, 2.42 mmol) in CH2Cl2/H2O 
(100 mL, 20:1) is added DDQ (775 mg, 3.4 mmol, 1.4 eq.) at 5 °C. The reaction is stirred for 
2 h at ambient temperature before it is quenched with sat. aq. NaHCO3. The mixture is diluted 
with MTBE, washed with aq. sat. NaHCO3 and brine, and the organic layer is dried and 
evaporated. Purification of the residue by flash chromatography (hexane/ethyl acetate, 20:1 
and 10:1) provides product S-9 (1.8 g, 89%) as a colorless oil. [ ]D20α = +1.4 (c = 1.00, CHCl3). 
1H NMR (300 MHz, CHCl3): δ 7.30-7.24 (m, 15 H), 5.88-5.74 (m, 1H), 5.03-4.58 (m, 8H), 
4.44 (d, 1H, J = 7.8 Hz), 3.89-3.80 (m, 3H), 3.71-3.58 (m, 3H), 3.48 (t, 1H, J = 9.6 Hz), 3.40 
(dd, 1H, J = 7.8, 9.1 Hz), 3.33 (m, 1H), 2.07-2.00 (m, 2H), 1.60-1.10 (m, 26H), 0.89 (s, 3H), 
0.08, 0.06 (2s, 3H). 13C NMR (75 MHz, CDCl3): δ 139.2, 138.6, 138.5, 128.4, 128.3, 128.2, 
128.0, 127.9, 127.8, 127.8, 127.6, 127.6, 114.0, 102.9, 84.8, 82.4, 77.7, 75.8, 75.0, 74.9, 62.6, 
58.6, 36.1, 33.8, 29.9-28.9, 25.9, 25.4, -5.4, -5.5. IR: 3539, 2926, 2854, 1640, 1070 cm-1. MS 
(ESI): m/z 853 ([M+Na]+). Anal. calcd. for C51H78O7Si: C 73.69, H 9.46, found C 73.77, H 
9.39.  
(3R)-3-[2,3,4-Tri-O-benzyl-6-O-(tert-butyldimethylsilyl)-β-D-glucopyranosyl]oxy-
octadec-17-enoic acid (24). A suspension of alcohol S-9 (1.6 g, 1.93 mmol) and PDC (4.4 g, 
11.58 mmol, 6 eq.) in dry DMF (10 mL) is stirred overnight (15 h) under Ar. After this time 
the reaction is diluted with ethyl acetate, the resulting solution is washed with sat. aq. 
NaHCO3 and brine before it is dried, filtered and evaporated. The residue is subjected to flash 
chromatography (hexane/acetone, 4:1) to give acid 24 as a colorless solid (900 mg, 55%). mp 
43-44 °C. [ ]D20α = +18.5 (c = 1.05, CHCl3). 1H NMR (300 MHz, CHCl3): δ 7.30-7.24 (m, 
15H), 5.87-5.74 (m, 1H), 5.04-4.61 (m, 8H), 4.47 (d, 1H, J = 7.8 Hz), 4.05 (m, 1H), 3.82 (dd, 
1H, J = 1.4, 11.2 Hz), 3.73 (dd, 1H, J = 5.2, 11.3 Hz), 3.64 (t, 1H, J = 9.1 Hz), 3.51 (t, 1H, J = 
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9.1 Hz), 3.41 (dd, 1H, J = 7.9, 9.3 Hz), 3.33 (ddd, 1H, J = 1.4, 5.0, 9.7 Hz), 2.67 (m, 2H), 2.3 
(m, 2H), 1.60-1.10 (m, 24H), 0.89 (s, 3H), 0.07, 0.06 (2s, 3H). 13C NMR (75 MHz, CDCl3): 
δ 172.7, 138.9, 138.1, 138.1, 138.0, 137.8, 114.1, 103.9, 84.7, 82.3, 78.4, 77.4, 76.2, 45.7, 
75.0, 75.0, 62.5, 41.1, 35.0, 29.6-29.9, 25.8, 25.4, 18.3, −5.3, −5.5. IR: 3031, 2926, 2854, 
1733, 1709, 1070 cm-1. HRMS (ESI): calcd. for (C51H76O8Si+Na): 867.5207, found 
867.5211 ([M+Na]+). 
 



















































































(S-10). A solution of compound 12 (1.0 g, 1.30 mmol) and tetrabutylammonium fluoride 
trihydrate (440 mg, 1.40 mmol) in THF (10 mL) is stirred at ambient temperature until TLC 
shows complete conversion of the substrate (ca. 2 h). Evaporation of the solvent gives a 
viscous oil which is purified by flash chromatography (hexane/ethyl acetate, 4:1) to yield 
alcohol S-10 as a colorless oil (1.0 g, 92%). [ ]D20α = +12.2 (c = 1.00, CHCl3). 1H NMR (400 
MHz, CDCl3): δ 7.28-7.20 (m, 15H), 4.96-4.53 (3AB, 6H), 4.49 (d, 1H, J = 7.8 Hz), 2.28 (d, 
1H, J = 10.8 Hz), 4.20 (dd, 1H, J = 4.5, 11.6 Hz), 4.04 (m, 1H), 3.65 (m, 1H), 3.63 (t, 2H, J = 
6.6 Hz), 3.48 (m, 2H), 3.40 (dd, 1H, J = 7.9, 9.1 Hz), 2.74 (dd, 1H, J = 5.4, 15.1 Hz), 2.42 
(dd, 1H, J = 8.0, 15.2 Hz), 2.02 (s, 3H), 1.65-1.15 (m, 26H), 1.44 (s, 9H).
 
13C NMR (100 
MHz, CDCl3): δ 170.7, 138.4, 138.3, 137.8, 128.4-127.6, 103.1, 84.8, 82.2, 80.3, 77.6, 77.4, 
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75.7, 74.9, 74.8, 72.7, 63.3, 63.1, 42.2, 34.6, 32.8, 29.7-29.4, 28.1, 25.7, 25.1, 20.8. IR: 3438, 
2926, 2854, 1744, 1728, 1367, 1070 cm-1. MS (ESI): m/z 855 ([M+Na]+). Anal. calcd. for 
C50H72O10 (833.05): C 72.08, H 8.71, found C 72.14, H 8.63. 
Compound S-12 [being (S)-Configured at C-17]. A mixture of PCC (430 mg, 2.0 mmol) 
and alcohol S-10 (830 mg, 1.0 mmol) is stirred in dichloromethane (20 mL) at room 
temperature for 1.5 h before it is poured onto a short column of silica gel. Elution with 
hexane/ethyl acetate (4:1) provides aldehyde S-11 (810 mg, 98 %) which is used directly to 
the next step. Characteristic data: [ ]D20α = +13.0 (c = 0.60, CHCl3). 1H NMR (400 MHz, 
CDCl3): δ 9.75 (t, 1H, J = 1.9 Hz), 7.30-7.20 (m, 15H), 4.96-4.53 (3AB, 6H), 4.49 (d, 1H, J = 
7.8 Hz), 4.30 (d, 1H, J = 11.8 Hz), 4.21 (dd, 1H, J = 4.5, 11.5 Hz), 4.65 (m, 1H), 3.49 (m, 
2H), 3.40 (dd, 1H, J 7.9, 9.1 Hz), 2.73 (dd, 1H, J = 5.4, 15.1 Hz), 2.44-2.34 (m, 3H), 2.02 (s, 
3H), 1.65-1.15 (m, 26H), 1.44 (s, 9H).
 
13C NMR (100 MHz, CDCl3): δ 202.9, 170.7, 170.6, 
138.4, 137.7, 128.4-127.6, 103.1, 84.8, 82.2, 80.4, 77.7, 77.4, 77.3, 75.7, 74.9, 74.8, 72.7, 
63.3, 43.9, 42.2, 34.6, 28.8-29.2, 28.1, 25.1, 22.1, 20.8. IR: 2926, 2854, 2717, 1743, 1727, 
1070 cm-1. MS (ESI): m/z 853 ([M+Na]+). 
A flame-dried flask is charged with trans-(1S,2S)-bis(trifluoromethyl-sulfonylamido)-
cyclohexane 39 (113 mg, 0.3 mmol), toluene (4mL) and Ti(OiPr)4 (700 µL, 3.0 mmol) and 
the resulting mixture is stirred at 40 °C for 30 min. After being cooled to –50 °C, the 
organozinc reagent 38 (3 mmol) and a solution of aldehyde S-11 (1 mmol) in toluene (2 mL) 
are successively added and the resulting mixture is slowly (1 h) warmed to –20 °C. The 
reaction is quenched by adding aq. sat. NH4Cl before it is diluted with MTBE and 
successively washed with HCl (1N), water and brine. The organic phase is dried (Na2SO4) 
and concentrated, and the residue is purified by flash chromatography (hexane/ethyl acetate, 
7:3) to yield alcohol S-12 as a colorless oil (800 mg, 77% over both steps). [ ]D20α = +5.3 (c = 
1.10, CHCl3). 1H NMR (400 MHz, CDCl3): δ  7.28-7.15 (m, 20H), 4.96-4.43 (4AB, 8H), 
4.48 (d, 1H, J = 7.7 Hz), 4.29 (d, 1H, J = 10.7 Hz), 4.20 (dd, 1H, J = 4.5, 11.7 Hz), 4.01 (m, 
1H), 3.69-3.44 (m, 5H), 3.40 (dd, 1H, J = 7.8, 9.1 Hz), 2.74 (dd, 1H, J = 5.4, 15.1 Hz), 2.40 
(dd, 1H, J = 8.0, 15.1 Hz), 2.02 (s, 3H), 1.62-1.17 (m, 36H), 1.43 (s, 9H), 1.18 (d, 3H, J = 6.1 
Hz).
 
13C NMR (100 MHz, CDCl3): δ 170.6, 138.4, 138.3, 137.8, 128.4-127.3, 103.1, 84.8, 
82.3, 80.3, 77.7, 77.4, 75.7, 74.9, 74.9, 74.8, 72.7, 72.2, 70.3, 63.3, 42.2, 37.5, 37.4, 36.6, 
34.6, 29.8-29.4, 28.1, 25.6, 25.6, 25.5, 25.1, 20.8, 19.6. IR: 3477, 2927, 2854, 1744, 1728, 
1070 cm-1. MS (ESI): m/z: 1059 ([M+Na]+). Anal. calcd. for C64H92O11: C 74.10, H 8.94, 
found C 73.86, H 8.89. 
Compound S-13. Alcohol S-12 (60 mg, 0.058 mmol) and trichloroacetimidate 41 (53 mg, 
0.087 mmol) are dissolved in CH2Cl2 and CH3CN (1:1, 8 mL) and the resulting solution is 
cooled to –50 °C before TMSOTf (5 µL) is added. The reaction mixture is stirred for 30 min 
at –40 °C before it is neutralized (triethylamine) and evaporated. The residue is purified by 
flash chromatography (hexane/ethyl acetate, 9:1) to give glycoside S-13 as a viscous oil (76 
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mg, 89%): [ ]D20α = −1.7 (c = 1.00, CHCl3). 1H NMR (400 MHz, CDCl3): δ  7.31-7.24 (m, 
35H), 4.95-4.43 (7AB, 14H), 4.50 (d, 1H, J = 7.8 Hz), 4.31 (d, 1H, J = 7.7 Hz), 4.29 (d, 1H, J 
= 9.8 Hz), 4.20 (dd, 1H, J = 3.7, 10.7 Hz), 4.03 (m, 1H), 3.72-3.46 (m, 9H), 3.58 (s, 3H), 
3.43-3.38 (m, 2H), 3.14-3.09 (td, 1H, J = 2.4, 8.1 Hz), 2.72 (dd, 1H, J = 5.4, 15.1 Hz), 2.40 
(dd, 1H, J = 7.9, 15.1 Hz), 2.02 (s, 3H), 1.63-1.16 (m, 36H), 1.43 (s, 9H), 1.19 (d, 3H, J = 6.1 
Hz).
 
13C NMR (100 MHz, CDCl3): δ 170.7, 170.6, 138.9, 138.4, 138.4, 138.3, 138.2, 137.7, 
128.4-127.3, 103.1, 102.7, 85.1, 84.3, 84.4, 82.2, 80.3, 80.2, 77.8, 77.6, 77.4, 75.7, 75.4, 74.9, 
74.8, 73.5, 72.7, 70.2, 69.2, 63.3, 60.5, 42.2, 36.6, 34.9, 34.6, 34.0, 29.9-29.5, 28.0, 25.5, 
25.3, 25.1, 25.0. IR: 2927, 2855, 1740, 1367, 1240, 1072 cm-1. MS (ESI): m/z: 1505 
([M+Na]+). Anal. calcd. for C92H122O16: C 74.46, H 8.29, found C 74.50, H 8.22. 
Compound 44: To a solution of disaccharide S-13 (40 mg, 0.026 mmol) in EtOAc (1 mL) 
and ethanol (2 mL) is added palladium on charcoal (10% w/w, 20 mg) and the resulting 
suspension is stirred under hydrogen atmosphere overnight. The catalyst is filtered off through 
a short pad of Celite and the filtrate is evaporated to give compound 44 as a colorless syrup 
(20 mg, 87%). [ ]D20α = −17.1 (c = 1.50, MeOH). 1H NMR (400 MHz, pyridine-d5): δ  4.92 (d, 
1H, J = 7.8 Hz), 4.86 (dd, 1H, J = 1.4, 12.8 Hz), 4.83 (d, 1H, J = 7.8 Hz), 4.73 (dd, 1H, J = 
5.8, 11.6 Hz), 4.52-4.42 (m, 2H), 4.31 (dd, 1H, J = 5.3, 11.9 Hz) 4.21-4.06 (m, 3H), 4.04-3.90 
(m, 5H), 3.83 (m, 1H), 3.82 (s, 3H), 3.41 (t, 1H, J = 8.2 Hz), 3.14 (dd, 1H, J = 5.6, 15.0 Hz), 
2.69 (dd, 1H, J = 7.8, 15.0 Hz), 2.02 (s, 3H), 1.80-1.15 (m, 36H), 1.48 (s, 9H), 1.34 (d, 3H, J 
= 6.1 Hz).
 
13C NMR (100 MHz, pyridine-d5): δ 170.9, 170.8, 104.4, 103.1, 85.4, 80.1, 79.4, 
78.3, 78.0, 77.8, 77.2, 75.1, 75.0, 72.0, 71.5, 67.0, 64.8, 63.0, 60.8, 49.2, 42.9, 40.2, 35.4, 
35.1, 34.3, 30.5, 30.2, 30.0, 29.9-29.8, 28.1, 27.0, 26.4, 25.6, 25.4, 25.3, 24.4, 20.8. 
Compound S-12 [with (R)-Configuration at C-17]. Prepared as described above for the (S)-
configured analogue. [ ]D20α = +5.7 (c = 1.20, CHCl3). 1H NMR (400 MHz, CDCl3): δ  7.33-
7.25 (m, 20H), 4.96-4.43 (4AB, 8H), 4.49 (d, 1H, J = 7.8 Hz), 4.30 (d, 1H, J = 11.3 Hz), 4.20 
(dd, 1H, J = 3.6, 10.7 Hz), 4.03 (m, 1H), 3.67-3.42 (m, 5H), 3.40 (t, 1H, J = 7.9 Hz), 2.75 (dd, 
1H, J = 5.4, 15.1 Hz), 2.40 (dd, 1H, J = 8.0, 15.1 Hz), 2.02 (s, 3H), 1.60-1.15 (m, 36H), 1.43 
(s, 9H), 1.18 (d, 3H, J = 6.1 Hz).
 
13C NMR (100 MHz, CDCl3): δ 170.7, 170.6, 139.1, 138.4, 
138.3, 137.7, 128.4-127.3, 103.1, 84.8, 82.3, 80.3, 77.6, 77.4, 75.7, 74.9, 74.8, 74.8, 72.7, 
71.9, 70.2, 63.3, 42.1, 37.5, 37.4, 36.3, 34.6, 29.7-29.4, 28.1, 25.7, 25.6, 25.5, 25.1, 20.7, 
19.6. IR: 2927, 2854, 1744, 1728, 1367, 1236, 1069 cm-1. MS (ESI): m/z 1060 ([M+Na]+). 
Anal. calcd. for C64H92O11: C 74.10, H 8.94, found C 74.15, H 8.99. 
Compound S-13 (C17-R). Prepared as described above for the (S)-configured analogue. (76 
mg, 89%). [ ]D20α = +5.2 (c = 1.00, CHCl3). 1H NMR (400 MHz, CDCl3): δ  7.34-7.18 (m, 
35H), 4.95-4.41 (7AB, 14H), 4.49 (d, 1H, J = 7.8 Hz), 4.32 (d, 1H, J = 7.8 Hz), 4.29 (d, 1H, J 
= 10.5 Hz), 4.20 (dd, 1H, J = 3.7, 10.5 Hz), 4.04 (m, 1H), 3.70-3.53 (m, 11H), 3.68 (s, 3H), 
3.10 (t, 1H, J = 7.8 Hz), 2.77 (dd, 1H, J = 5.4, 15.1 Hz), 2.41 (dd, 1H, J = 7.9, 15.1 Hz), 2.01 
(s, 3H), 1.60-1.15 (m, 36H), 1.42 (s, 9H), 1.16 (d, 3H, J = 6.1 Hz).
 
13C NMR (100 MHz, 
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CDCl3): δ 170.7, 170.6, 138.9, 138.4, 138.4, 138.3, 138.3, 137.8, 128.4-127.4, 103.1, 102.7, 
85.1, 84.8, 84.5, 82.3, 80.3, 80.2, 77.8, 77.6, 77.4, 75.7, 75.5, 74.9, 74.9, 74.8, 73.5, 72.7, 
70.2, 69.3, 63.3, 60.6, 42.2, 36.7, 34.8, 34.6, 34.0, 29.9-29.5, 28.1, 25.6, 25.3, 25.1, 20.8, 
19.6; IR: 2927, 2855, 1728, 1454, 1366, 1071 cm-1. MS (ESI): m/z 1506 ([M+Na]+). Anal. 
calcd. for C92H122O16: C 74.46, H 8.29, found C 74.29, H 8.33. 
Compound 45: Prepared as described above for the (S)-configured analogue (15 mg, 96%). 
[ ]D20α = −17.2 (c = 1.50, MeOH). 1H NMR (400 MHz, pyridine-d5): δ  4.92 (d, 1H, J = 7.8 
Hz), 4.88 (dd, 1H, J = 1.4, 11.6 Hz), 4.84 (d, 1H, J = 7.8 Hz), 4.74 (dd, 1H, J = 5.7, 11.6 Hz), 
4.50-4.45 (m, 2H), 4.33 (dd, 1H, J = 5.3, 11.9 Hz) 4.18-4.09 (m, 3H), 4.02-3.92 (m, 5H), 3.84 
(m, 1H), 3.82 (s, 3H), 3.42 (t, 1H, J = 8.3 Hz), 3.14 (dd, 1H, J = 5.6, 15.0 Hz), 2.70 (dd, 1H, J 
= 7.8, 15.0 Hz), 2.02 (s, 3H), 1.82-1.20 (m, 36H), 1.48 (s, 9H), 1.31 (d, 3H, J = 6.1 Hz).
 
13C 
NMR (100 MHz, pyridine-d5): δ 170.9, 170.8, 104.4, 103.5, 85.4, 80.1, 79.4, 78.3, 78.0, 77.8, 
77.2, 75.1, 75.0, 72.0, 71.5, 71.2, 67.0, 64.8, 63.0, 60.8, 49.2, 42.9, 40.2, 35.4, 35.1, 34.4, 
30.3, 30.0-29.9, 28.1, 26.4, 25.6, 25.4, 25.3, 24.3, 20.8, 19.2. 
 
Spectroscopic Properties of the Compounds Used in the Antiviral Assays 
 
Compound 70. [ ]D20α = +6.8 (c = 0.60, MeOH). 1H NMR (400 MHz, CD3OD): δ 4.45 (dd, J 
= 1.9, 11.7 Hz, 2H), 4.31 (d, J = 7.8 Hz, 2H), 4.00 (m, 2H), 3.97 (dd, J = 7.9, 11.7 Hz, 2H), 
3.51 (m, 4H), 3.44 (m, 2H), 3.32 (t, J = 8.9 Hz, 2H), 3.20 (t, 2H), 3.14 (dd, J = 7.8, 8.9 Hz, 
2H), 3.95 (dd, J = 5.1, 15.3 Hz, 2H), 2.42 (dd, J = 8.2, 15.3 Hz, 2H) 1.60-1.25 (m, 52H). 13C 
NMR (100 MHz, CD3OD): δ 172.9, 105.6, 79.0, 77.9, 75.2, 74.8, 72.1, 65.4, 63.0, 42.7, 36.3, 
33.6, 30.7-30.6, 26.9, 26.2. IR: 3421, 2921, 2851, 1735, 1083 cm-1. HRMS (ESI): m/z calcd. 
for (C46H84O16+Na): 915.5657, found 915.5665 ([M+Na]+). 
Compound 71. mp 117-118 °C. [ ]D20α = +2.3 (c = 1.20, MeOH). 1H NMR (400 MHz, 
CD3OD): δ 4.31 (d, J = 7.8 Hz, 1H), 4.06 (m, 1H), 3.81 (dd, J = 2.4, 12.0 Hz, 1H), 3.65 (s, 
3H), 3.62 (dd, J = 5.6, 12.1 Hz, 1H), 3.62 (t, J = 6.6 Hz, 2H), 3.34-3.18 (m, 3H), 3.12 (dd, J = 
7.9, 9.0 Hz, 1H), 2.71 (dd, J = 6.4, 15.4 Hz, 1H), 2.50 (dd, J = 5.5, 15.4 Hz, 1H), 1.70-1.15 
(m, 26H). 13C NMR (100 MHz, CD3OD): δ 174.3, 104.2, 78.0, 77.9, 77.7, 75.2, 71.7, 63.0, 
62.9, 52.1, 41.9, 35.9, 33.7, 30.7-30.6, 26.9, 26.1. IR: 3349, 2922, 2851, 1734, 1086, 1047 
cm-1
.
 HRMS (ESI): m/z calcd. for (C24H46O9+Na): 501.3039, found 501.3040 ([M+Na]+). 
Compound 72. mp 113-114 °C; [ ]D20α = +3.0 (c = 1.10, MeOH); 1H NMR (400 MHz, 
CD3OD): δ 4.91 (dd, J = 3.2, 11.5 Hz, 1H), 4.60 (s, 1H), 4.05 (t, J = 10.1 Hz, 1H), 4.01 (d, J 
= 11.6 Hz, 1H), 3.71 (d, J = 4.4 Hz, 1H), 3.66 (m, 1H), 3.56 (dd, J = 3.0, 9.8 Hz, 1H), 3.53 (t, 
J = 6.7 Hz, 2H), 3.40 (dd, J = 4.4, 10.3 Hz, 1H), 2.47 (t, J = 11.2 Hz, 1H), 2.36 (dd, J = 2.1, 
11.3 Hz, 1H), 1.60-1.25 (m, 26H). 13C NMR (100 MHz, CD3OD): δ 176.2, 107.7, 81.2, 79.3, 
78.9, 78.3, 67.1, 64.2, 63.0, 44.3, 38.5, 33.7, 30.7-30.5, 26.9, 26.6. IR: 3412, 2918, 2850, 
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1699, 1070, 1057, 1030 cm-1. HRMS (ESI): m/z calcd. for (C23H42O8+Na): 469.2777, found 
469.2776 ([M+Na]+). 
Compound 73. mp 92-93 °C. [ ]D20α = −27.5 (c = 0.45, MeOH). 1H NMR (400 MHz, 
CD3OD): δ 4.37 (d, J = 7.9 Hz, 1H), 4.35 (d, J = 7.9 Hz, 1H), 3.89 (m, 1H), 3.82 (m, 2H), 
3.67-3.60 (m, 3H), 3.56 (s, 3H), 3.55 (s, 3H), 3.35 (dd, J = 1.1, 8.9 Hz, 2H), 3.26 (dd, J = 2.8, 
8.9 Hz, 2H), 3.19 (m, 2H), 2.81 (m, 2H), 1.65-1.25 (m, 12H), 1.16 (d, J = 6.2 Hz, 3H), 0.91 (t, 
J = 7.5 Hz, 3H). 13C NMR (100 MHz, CD3OD): δ 103.7, 102.3, 85.2, 84.9, 82.0, 77.8, 77.7, 
75.7, 71.8, 62.9, 61.1, 61.0, 38.4, 34.4, 31.0, 28.7, 26.3, 26.0, 19.7, 9.9. IR: 3433, 2931, 1460, 
1374, 1079, 1062, 1021 cm-1. HRMS (ESI): m/z calcd. for (C24H46O12+Na): 549.2887, 
found 549.2889 ([M+Na]+). 
